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ABSTRACT 
This study examined potential differences in youth (aged 7-17 years, 76% Caucasian, 
52% female) with comorbid asthma and anxiety compared to youth with anxiety without 
asthma who received cognitive-behavioral therapy (CBT) alone, pharmacotherapy alone, 
the combination of pharmacotherapy or placebo pill in the Child/Adolescent Multimodal 
Study. Two groups were compared on negative self-talk; number of physical symptoms; 
parental anxiety; content of their worries; and presence of panic, generalized anxiety, and 
separation anxiety disorders across treatment conditions. Findings indicated that youth 
with asthma and anxiety were more likely to exhibit higher rates of negative self-talk than 
youth without asthma, possibly related to the realistic nature of asthma-related anxiety. 
This study also demonstrated that youth with asthma and anxiety demonstrated similar 
responses to traditional CBT when compared to youth without asthma. Given the large 
sample size, these findings support that traditional CBT and pharmacotherapy for anxiety 
may be an effective treatment for youth with mild to moderate asthma. Further research is 
needed to determine the efficacy of traditional CBT for youth with severe asthma.   
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CHAPTER 1: INTRODUCTION 
Statement of the Problem 
More than 8% of children suffer from asthma, making it the most common 
chronic illness diagnosed in children (Centers for Disease Control [CDC], 2017). Asthma 
is characterized by an inflammation of the airways, making breathing difficult (National 
Institute of Health [NIH], 2014). Symptoms present as chronic, with daily symptoms of 
breathing difficulties, or episodic, with occasional episodes of severe symptoms. In the 
latter case, children and adults with asthma may require hospitalization to manage asthma 
attacks (NIH, 2014). Asthma is often treated with short-term medications to target daily 
symptoms and long-term medications to prevent and reduce the severity of asthma 
attacks (McQuaid & Walders, 2003). Asthma treatment requires a level of adherence to 
medication and an action plan for monitoring symptoms (Bruzzese, Carcone, Lam, Ellis, 
& Naar-King, 2014; Farrel, Donovan, Turner, & Walker, 2011; Tiggelman, van de Ven, 
van Schayck, & Engels, 2015).  Psychological comorbidities can often reduce asthma 
adherence and increase complications related to the condition.  
Anxiety disorders and asthma are frequently comorbid conditions (Meuret, 
Ehernreich, Pincus, & Ritz, 2006). Research indicates that the prevalence of anxiety 
disorders is higher in children with asthma than in the general population (Meuret et al., 
2006). Individuals diagnosed with asthma present with increased panic disorder (PD), 
generalized anxiety disorder (GAD), and separation anxiety disorder (SAD; Roy-Byrne et 
al., 2008). Anxiety and asthma comorbidity is linked to various negative health 
conditions (Roy-Byrne et al., 2008; Vila et al., 2003). Individuals with asthma and 
anxiety may have poor asthma control and an increased use of medication compared to 
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children with asthma but without anxiety. Children with anxiety coping with asthma are 
also more likely to report an increase in severity of asthma symptoms, use of healthcare 
resources, and costs associated with healthcare than are children without anxiety (Roy-
Byrne et al., 2008; Vila et al., 2003).   
Previous psychosocial treatment modalities have separately addressed asthma 
management and anxiety in children, with only recent research integrating the treatment 
and adherence of both disorders into one protocol (Sicouri et al., 2017a). Cognitive-
behavioral therapy (CBT) is a treatment that can address the behavioral components of 
both asthma and anxiety (e.g., treatment adherence, avoidance of potential triggers) along 
with cognitions that may accompany both conditions (e.g., I will fail, I am going to have 
an asthma attack at school). However, the research on CBT treatments for comorbid 
anxiety and asthma is limited. In one study, children with this comorbidity showed some 
improvement in response to CBT for anxiety, yet the improvement was not as significant 
as the improvement for children with anxiety without medical diagnoses (Papneja & 
Manassis, 2006). Other research has demonstrated that CBT paired with asthma 
education may be effective in helping adults and children with comorbid asthma and 
anxiety (Ross, Davis, & Macdonald, 2005; Sicouri et al., 2017a). However, small sample 
sizes make difficult the generalization of the current research to all youth experiencing 
comorbid asthma and anxiety.  More information is needed to determine the best type of 
psychological treatment to decrease symptoms, increase adherence, and increase quality 
of life (QOL) for children experiencing comorbid asthma and anxiety.  
Why have traditional CBT anxiety treatments failed to significantly improve the 
life and outcome of individuals with comorbid asthma and anxiety? What are some of the 
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differences between individuals with this comorbidity and youth with anxiety disorders 
who do not suffer from asthma? What may be interfering with the success of CBT 
treatments, specifically for these individuals? To answer these questions, an 
understanding of the characteristics unique to these individuals and of how these 
characteristics may moderate CBT treatment outcomes is necessary.  
CBT for anxiety targets several behavioral and cognitive components that may 
maintain a child’s anxiety. While not every child with anxiety develops an anxiety 
disorder in the same way, cognitive vulnerabilities, parental facilitation, and learning 
experiences contribute to the development and maintenance of anxiety in children. 
Cognitive vulnerabilities that may increase the likelihood of developing anxiety in 
childhood include negative self-talk (Kendall & Treadwell, 2007) and anxiety sensitivity 
(Muris, Mayer, Freher, Duncan, & van den Hout, 2010). Family factors often contribute 
to the development and maintenance of anxiety in children through family stress, parental 
psychopathology, and parental accommodation (Pahl, Barrett, & Gullo, 2012; Thompson-
Hollands, Kerns, Pincus, & Corner., 2014). Classical conditioning, social learning, and 
instructional learning also increase a child’s susceptibility to developing anxiety 
(Domjan, 2018; McCleod, Wood, & Avny, 2011; Rachman, 1977). To complicate things 
further, an asthma comorbidity may interact with these various factors, potentially 
increasing susceptibility in children with asthma and anxiety.  
Children with anxiety disorders often present with higher levels of negative self-
talk than those of children without anxiety (Kendall & Treadwell, 2007). Negative self-
talk is comprised of various self-statements characterized by common themes of threat 
and harm typically specific to the child’s fears or worries (Kendall & Treadwell, 2007). 
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These self-statements are associated with higher levels of anxiety in children and may 
contribute to an increase in severity of anxiety symptoms (Treadwell & Kendall, 1996). 
However, in regard to negative self-talk, children with asthma and anxiety comorbidities 
may differ from children with anxiety alone. While research is still limited on negative 
self-talk in children with this comorbidity, the current literature suggests that children 
with comorbid asthma and anxiety may focus more on health worries than on other forms 
of anxious self-talk (e.g., social worries, academic worries; Lind, Nordin, Palmquist, & 
Nordin, 2014; Lowther, Newman, Sharp, & McMurray, 2016). Studies of adults have 
demonstrated that increased anxiety and asthma comorbidity is associated with increased 
health-related worries (Lind et al., 2014). Therefore, children with asthma and anxiety 
may not necessarily have less negative self-talk; however, the content of the self-talk may 
differ from that of children without an asthma comorbidity.  
 Many children with anxiety also present with increased anxiety sensitivity, which 
prompts these children to appraise physical symptoms as threatening or dangerous (Muris 
et al., 2010). They may misconstrue increased heart rate, difficulty breathing, or other 
physical symptoms as symptoms indicative of danger rather than as anxiety-related 
somatic symptoms. An increase in anxiety sensitivity may be related to anxiety disorders, 
such as panic disorder (Viana, Kiel, Alfano, Dixon, & Palmer, 2017). Increased anxiety 
sensitivity is also present in individuals with comorbid asthma and anxiety (Avallone, 
McLeish, Lubero, & Bernstein, 2012). However, given the nature of asthma treatment, 
discerning anxiety sensitivity from adaptive awareness of physical symptoms is difficult. 
Awareness of symptom presentation is an important aspect of asthma treatment 
management (Farrell et al., 2011), yet some children with anxiety sensitivity may 
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overread physical symptoms, misinterpreting somatic anxiety symptoms as a warning of 
an oncoming asthma exacerbation.    
Family factors also contribute to the development and maintenance of anxiety 
disorders in children. Family stress, parental psychopathology, and parental 
accommodation act as contributing factors to childhood anxiety (Pahl et al., 2012; 
Thompson-Hollands et al., 2014). Both traumatic events and everyday stressors can 
interact with a child’s ability to cope and manage stress (Thompson-Hollands et al., 
2014). Additionally, stressors can increase parental psychopathology, thus impacting a 
child’s own psychopathological development through learning, parental styles, and the 
development of coping skills (Pahl et al., 2012; Sales, Fivush, & Teague, 2008). Parents 
can also increase the maintenance of anxiety disorders through accommodation. 
Accommodation occurs when parents reduce a child’s anxiety by removing the child 
from the anxiety-provoking situation (Lebowitz et al., 2013). While accommodation can 
be helpful in dangerous situations, accommodation can prevent a child from learning new 
associations with various situations and fear stimuli. Parental accommodation and 
modeling may stem from their own psychopathologies. Parents may increase their 
accommodation because of previous physical threats related to legitimate asthma 
concerns; however, accommodations may also increase when children are faced with 
nondangerous situations or triggers. Increased severity in asthma symptoms in children is 
associated with a trauma history in parents (Wamboldt, Weintraub, Krafchik, Berce, & 
Wamboldt, 1995). Children with asthma also demonstrated increased anxiety symptoms 
when at least one parent had a history of psychopathology (Feldman, Ortega, Koinis-
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Mitchell, Kuo, & Canino, 2010). These findings suggest that parental psychopathology 
may act as a risk factor for increased anxiety in children with asthma.  
Finally, children may develop anxiety-related thoughts and behaviors through 
learning. Classical conditioning may increase a child’s inclination to view seemingly 
neutral stimuli as threatening (Domjan, 2018). Furthermore, children may learn to fear 
certain objects or situations as the result of parental information or transmission of fears 
from the parents (McCleod et al., 2011; Rachman 1977). Children with asthma have also 
demonstrated an increase in asthma-related symptoms in response to context clues – 
symptoms that do not have any biological indicators of pulmonary dysfunction (De 
Peuter, Lemaigre, Diest, & Van den Bergh, 2008; Rietveld & Brosschot, 1999). Parental 
psychopathology may also explain an increase of fear learning in children with asthma 
(Wright, Reiser, & Delparte, 2017). Children with asthma and anxiety learn to fear 
physical symptoms, potentially asthma-inducing situations, and potential triggers, in part 
through contextual learning and parental instruction and modeling.  
Overall, while research has examined some of the factors that may be related to 
psychological treatment of asthma and anxiety comorbidity, more information is needed 
to truly understand the profile of children struggling with asthma and anxiety 
comorbidity. Children with comorbid asthma and anxiety may present to treatment with 
higher rates of physical symptoms than children without asthma, as a result of the 
physiological nature of their medical condition and the increased awareness of physical 
symptoms related to asthma management strategies. These children may also present with 
negative self-talk that has different themes than that of children with anxiety alone. 
Specifically, the negative self-talk may focus more on physical- and health-related 
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worries than on worries regarding academics or social situations. Given the physical 
nature of asthma, children with asthma and anxiety sensitivity may be at higher risk for 
developing panic disorder than children without asthma. In addition, parental 
psychopathology may increase the presence of GAD or SAD in children with asthma, 
potentially as a result of vicarious or informational learning about increased asthma 
health risks. The differences in children with asthma and anxiety comorbidity may impact 
traditional CBT treatments for anxiety disorders, necessitating the integration of 
addressing asthma-related symptoms into treatment for children with asthma and anxiety.  
Purpose of the Study 
 Anxiety and asthma are two of the most prevalent conditions facing children 
(Merikangas, Nakamura, & Kessler, 2009; Meuret et al., 2006). Owing to the negative 
health consequences associated with a comorbidity of anxiety and asthma, the 
development of specific treatments for these children may be important. Research on 
CBT treatments for asthma and anxiety comorbidities is mixed and limited in 
determining an effective course of treatment for these individuals. More information is 
needed to understand the presentation of anxiety in children with asthma, and the factors 
that may differentiate them from patients without asthma anxiety. Understanding these 
characteristics may help researchers and clinicians explain why current treatments may 
not be effective and how to effectively treat youth with asthma and anxiety. The purpose 
of this study is to investigate the differences between children with anxiety and asthma 
and children with anxiety without asthma. Specifically, this study aims to determine if 
negative self-talk, content of worries, parental psychopathology, and presentation of 
physical symptoms are different in children with anxiety with asthma and without 
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asthma. This study also aims to determine if children with comorbid asthma and anxiety 
present with higher rates of panic, generalized anxiety, and separation anxiety symptoms 
when compared to youth without asthma. This study further aims to determine if 
outpatient CBT in a clinical setting is as effective in treating anxiety in a medically 
comorbid sample when compared to a nonmedical sample. The results of this study may 
help determine best practices for informing CBT treatments for children with a comorbid 
diagnosis of asthma and anxiety.  
Hypotheses 
This study utilized archival data from the Child/Adolescent Anxiety Multimodal 
Study (CAMS) trial (Walkup et al., 2008), a randomized control trial comparing 
cognitive-behavioral therapy (CBT) with sertraline therapy for the treatment of childhood 
anxiety. The following hypotheses were proposed: 
Hypothesis 1 
Hypothesis 1: Children with comorbid asthma and anxiety would exhibit higher 
levels of physical symptoms (PSC), panic symptoms (SCARED), generalized anxiety 
symptoms (SCARED), separation anxiety symptoms (SCARED), and parental anxiety 
(STAI), when compared to children without comorbid asthma. A power analysis was 
computed and determined that 234 subjects were required for a medium effect size at .05 
with a power of α = .80. 
Hypothesis 2 
Hypothesis 2: Children with comorbid asthma and anxiety would demonstrate less 
general negative self-talk (NASSQ) than children with anxiety but without asthma. A 
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power analysis was computed and determined that 200 subjects were required for a 
medium effect size at .05 with a power of α = .80. 
Hypothesis 3 
Hypothesis 3: Children with comorbid asthma and anxiety would demonstrate 
higher occurrences of physical/natural worries (CQ-C) than children with anxiety but 
without asthma. A power analysis was computed and determined that 143 subjects were 
required for a medium effect size at .05 with a power of α = .80.  
Hypothesis 4 
Hypothesis 4: Children with comorbid asthma and anxiety would be less likely to 
be a treatment responder than children with anxiety but without asthma. Alternatively, 
children with comorbid asthma and anxiety would demonstrate higher levels of anxiety 
(PARS) in response to the treatment conditions (CBT, Sertraline, Combined CBT and 
Sertraline, and Placebo) when compared to children with anxiety but without asthma. A 
power analysis was computed and determined that 200 subjects were required for a 
medium effect size at .05 with a power of α = .80. 
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CHAPTER 2: REVIEW OF THE LITERATURE 
Childhood Asthma 
 Asthma is such a common illness in childhood that it is discussed by medical 
professionals and families on a daily basis. Children and adults throughout the world 
suffer from this chronic illness that inflames and narrows the airways and causes 
difficulty in breathing (National Institute of Health [NIH], 2014). Individuals may 
experience chronic symptoms in response to the inhalation of substances (e.g., dog hair, 
cigarette smoke) on a daily or weekly basis. Constricted airways may require mild 
medical intervention, such as an inhaler, to reduce impact on breathing (NIH, 2014). 
Exposure to triggering substances causes the muscles around airways to tighten, reducing 
airflow in the lungs. Additionally, airways may swell and fill with mucus, further 
restricting airflow. Chronic symptoms may include wheezing, coughing, tightness of 
chest, and shortness of breath (Lowther, Newman, Sharp, & McMurray, 2016). However, 
despite its chronic nature, asthma can also have episodes of severe symptoms resistant to 
common medical intervention. In these cases, patients with asthma require emergency 
medicine to manage and reduce symptoms (NIH, 2014).   
 Asthma is a condition that varies from child to child. Chronic symptoms may not 
be detectible, or may produce only minor irritation (McQuaid & Walders, 2003). In other 
situations, a child may experience significant asthma attacks, or exacerbations, in which 
symptoms are more severe and active. During acute exacerbations, the airways constrict 
and narrow to reduce exposure to stimuli, also referred to as bronchoconstriction 
(National Asthma Education and Prevention Program [NAEPP], 2007). This disorder 
may persist over time or may fall into remission (NAEPP, 2007). 
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 Severity and progression of asthma greatly depend on the child’s age (NAEPP, 
2007). Children who are diagnosed with asthma before the age of 3 years often have a 
worse prognosis when entering early adolescence than other children who experienced 
asthma symptoms later in childhood. This early diagnosis is associated with lung function 
deficits and atypical lung growth. Overall, age of onset and current age of the child are 
more highly predictive of symptom severity than are environmental factors.  
 While asthma puts children at risk for severe health problems and potential death, 
it also increases risk for many other environmental problems (Farrell et al., 2011; Sales et 
al., 2008). Children with asthma may also be at risk for school absences, perhaps 
interfering with their academic performances. Additionally, these children may 
experience social restrictions because of their asthma (Farrell et al., 2011). For example, 
a child may not be able to attend a sleepover because he or she may be at risk for an 
asthma attack, or the friend may have pets that trigger the child’s asthma. Overall, asthma 
presents many social and community limitations to a child’s life.  
Prevalence 
 Asthma affects at least 8.4% of children in the United States, and the rates 
continue to rise each year (Akinbami, Moorman, Garbe, & Sondik, 2009). Asthma is 
initially more prevalent in boys, but the ratio of diagnoses evens out as children reach 
puberty (NAEPP, 2007). Children with mixed ethnic backgrounds have the highest rates 
of asthma (14.1%), while the lowest rates are seen in Asian Americans (5.2%; Centers for 
Disease Control [CDC], 2017). Asthma is also more often diagnosed in lower income 
populations, where at least 11.2% of children with asthma fall under the poverty line.  
Although asthma is prevalent among all demographics, it is most prevalent in lower 
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socioeconomic status minority youth (McQuaid & Walders, 2003). This prevalence may 
be related to specific environmental triggers in lower income neighborhoods (e.g., dust, 
air pollution) or to an increase in severity associated with the reduced access to healthcare 
in low-income neighborhoods (Pearlman et al., 2006).  
 Patients with asthma are often more likely to use healthcare services than are 
individuals without a chronic medical condition. While use of primary-care settings in 
asthma-related cases is declining, emergency department rates are maintaining stability 
across time (CDC, 2017). Approximately 1.8 million people are admitted to the 
emergency room each year as the result of asthma-related symptoms, while asthma-
related physician visits are estimated at 14.2 million per year (Asthma and Allergy 
Foundation of America, 2017). Asthma-related problems include healthcare costs 
estimated at $56 million per year and 13.8 missed school days (Asthma and Allergy 
Foundation of America, 2017). Asthma is a condition that involves the use of many 
resources and prevents children from engaging in normal academic attendance.  
Medical Treatments 
 Medical treatment of asthma depends on the level of care needed and the severity 
of symptoms. Different levels of healthcare providers may also be involved, depending 
on the severity of the condition (McQuaid & Walders, 2003). Daily management and 
mild symptoms may be treated by a primary-care physician or pediatrician. However, 
more severe symptoms may be treated by a pulmonologist or allergist. Complicated cases 
may require the referral of a pediatric asthma specialist, who is more qualified than a 
general provider to manage severe asthma that may be at a higher risk for morbidity 
(McQuaid & Walders, 2003).  
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 The overall goal of asthma treatment is to reduce the number of exacerbations and 
active symptoms (Mayo Clinic, 2019). By treating the main symptoms, healthcare 
professionals also aim to reduce use of short-term asthma medications, physical 
limitations, and school absences. Asthma treatment includes a combination of 
medication, exacerbation prevention, and an asthma action plan to target mild symptoms, 
increase symptom perception, measure peak flow, and choose an appropriate level of care 
for more severe symptoms (Farrell et al., 2011; Mayo Clinic, 2019). Patients have also 
shown to benefit from asthma education, from which they learn more about the disorder, 
potential causes, and treatment options (Farrell et al., 2011).  However, the first level of 
care is determining which asthma medication is appropriate given the child’s presenting 
asthma symptoms.  
 Asthma medication is typically classified into two categories: short-term relief 
medications and long-term control medications (Mayo Clinic, 2019; McQuaid & 
Walders, 2003). Table 1 outlines the common short-term and long-term medications used 
for asthma. Short-term medications are intended for quick relief during the event of an 
asthma exacerbation (Mayo Clinic, 2019). They are additionally used before any 
strenuous activity, such as exercise or sports. Long-term medications aim to reduce the 
overall inflammation in the patient’s respiratory system (Mayo Clinic, 2019). A 
combination of long-term prevention medications and short-term relief medications 
provides the best treatment and maintenance for asthma symptoms. Although incidence is 
low (approximately 3%), some children may experience anxiety as a side effect of long-
term corticosteroid use (Ciriaco et al., 2013). This similarity between anxiety and asthma 
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may be related to some of the physical sensations caused by the medication, including 
increased heart rate.  
Table 1 
Medications for Chronic and Acute Asthma Symptoms 
Short-term medications Long-term medications 
Anticholinergeics – relieve acute 
bronchospasms; relax airways; reregulate 
breathing 
Inhaled corticosteroids – reduce overall airway 
inflammation and prevent use of short-term 
medications 
Beta antagonists – relieve acute symptoms 
by relaxing smooth muscles; prevent airway 
from becoming constricted during physical 
activity 
Oral and systemic corticosteroids – control some 
of the chronic symptoms; helpful at maintaining 
control during stabilization of long-term 
medications  
Oral corticosteroids – moderate to severe 
attacks, with more long-term effects; 
however, may have more severe side effects 
Cromolyn sodium and nedocromil sodium – 
long-term prevention of symptoms; most 
effective when administered prior to triggers 
 
Leukotrine modifiers – prevent exacerbations 
within 24 hours 
 
Methylxanthines – reduce persistent nocturnal 
symptoms  
 
Combined inhalers – contain inhaled 
corticosteroid and long-acting beta antagonists;  
long-term control of bronchospasms and anti-
inflammatory 
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 In addition to medication, treatment adherence is extremely important to the 
reduction of asthma symptoms. Consistent use of medications is required to prevent 
hospital admissions and emergency room visits (Herndon, Mattke, Cuellar, Hong, & 
Shenkman, 2012). Nonadherence to asthma regimens is associated with asthma-related 
death (Bruzzese et al., 2014). Nonadherence to medication may additionally reduce the 
overall effectiveness of reducing asthma symptoms (Murphy et al., 2012; Tiggelman et 
al., 2015). Medical adherence with asthma is associated with many factors, including 
relationship with the physician (Bruzzese et al., 2014) and better quality of life (QOL; 
Tiggelman et al., 2015).  
 In a study conducted by Bruzzese et al. (2014), the researchers demonstrated that 
family routines associated with asthma maintenance were predictive of treatment 
adherence in a sample of African American adolescents. As the family shares the 
responsibility of medication management, adolescents learn to develop routines for 
regular asthma treatment. Parental modeling may help these adolescents develop their 
own competencies in medication routines, resulting in asthma management becoming 
less intrusive and more habitual. Findings also indicated that parental support was 
correlated with, but not predictive of, medical adherence (Bruzzese et al., 2014), 
reflecting the growing autonomy that often accompanies adolescent development.  
 In a longitudinal study, Tiggelman et al. (2015) demonstrated that QOL was 
predictive of better medical adherence over 3 years. Adolescents with a higher QOL at 
baseline were more likely to maintain medication adherence at the end of the 3-year 
period. Adolescents may associate their QOL with reduced symptoms as a result of 
medication adherence (Tiggelman et al., 2015). However, the study also demonstrated 
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that overall medical adherence decreased over time. This decrease may be the result of 
adolescents’ lack of education regarding the importance of medication maintenance or of 
their perception that the medication is no longer necessary. Yet, this decrease in 
adherence was not associated with worsening asthma symptoms (Tiggelman et al., 2015).  
Findings demonstrate the importance of a higher QOL on overall maintenance of asthma 
symptoms. Children who may have comorbid psychopathology may not be as likely to 
adhere to medical recommendations than children without a psychological comorbidity.  
 Research has demonstrated that medical adherence is important for asthma control 
(Bruzzese et al., 2014; McQuaid & Walders, 2003; Tiggelman et al., 2015).  Controlling 
asthma symptoms through medication management and trigger avoidance can help 
reduce the occurrence of asthma exacerbations (McQuaid & Walders, 2003) and 
mortality associated with asthma (Bruzzese et al., 2014). However, more research is 
needed to determine the factors most efficient at increasing medical adherence among 
children and adolescents. While family routines (Bruzzese et al., 2014) and a high QOL 
(Tiggelman et al., 2015) may be helpful in increasing medical compliance, many patients 
with asthma still struggle to adhere to effective asthma treatment plans. In some cases, 
adherence may be more difficult for children who have a parent struggling with 
psychopathology or family stress. More research is needed to understand the best method 
for increasing medical compliance in patients with asthma, especially when other factors, 
such as psychological comorbidity, may interfere with QOL.  
Currently, asthma action plans are used to develop a daily regimen for children to 
help reduce their symptoms and increase treatment adherence (Farrell et al., 2011). 
Within these action plans, children are encouraged to identify their asthma triggers. 
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Triggers can be environmental (e.g., animals, smoke, pollen), emotional (e.g., crying, 
anger), and physical (e.g., exercise, dancing). By identifying triggers, the children can 
learn to avoid the stimuli or be prepared when confronted by the trigger. Additionally, 
action plans include the monitoring of peak flow – the indication that the airway is 
changing or narrowing (Farrell et al., 2011). Action plans help children monitor when 
their airways may be narrowing, allowing them either to take medication or to figure out 
the next steps of their healthcare plan. Action plans also help children with symptom 
perception training (Farrell et al., 2011), allowing children to learn when even the 
slightest symptoms are present, prompting them to take action with medication or get 
medical help before symptoms become too severe. However, increasing children’s 
perceptions of their asthma symptoms may also increase their perceptions of non-asthma-
related physical symptoms, potentially increasing their anxiety about their health. As 
many asthma symptoms overlap with the physical symptoms of anxiety, symptom 
perception training may be teaching children to become more sensitive to all the physical 
sensations in their bodies.  
Asthma and Anxiety Comorbidity 
 Children with asthma are at increased risk of developing anxiety disorders (Katon 
et al., 2007; Lu et al., 2012). In a recent meta-analysis, Lu et al. (2012) found that 
adolescents with asthma were significantly more likely to develop anxiety when 
compared to healthy controls. Specifically, 33% of adolescents with asthma experienced 
comorbid anxiety, while 21% of healthy adolescents experienced anxiety. Findings have 
demonstrated that children with asthma are at increased risk of developing anxiety 
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disorders; however, research is still exploring whether asthma diagnosis and treatment 
acts as a pathway to certain anxiety disorders.  
 Asthma is highly comorbid with panic disorder, separation anxiety disorder 
(SAD), and generalized anxiety disorder (GAD; Katon et al., 2007; Lu et al., 2012; Roy-
Byrne et al., 2008). These comorbidities may result from many factors. Children with 
asthma may develop hypervigilance and fear toward their somatic symptoms, resulting in 
increased panic attacks (Lu et al., 2012). Asthma and anxiety comorbidity is associated 
with increased somatic complaints, perhaps explaining diagnoses of panic disorder and 
GAD (Farrell et al., 2011). These children may experience increased chest tightness, 
wheezing, and coughing, which may mimic panic symptoms. Asthma exacerbations are 
also often paired with anxiety and fear, and children may develop a learned aversion to 
environmental and situational triggers of asthma (e.g., animals, physical activity; Farrell 
et al., 2011). Furthermore, children with asthma may develop separation anxiety as they 
may fear what would happen to them if separated from a caregiver.  
Childhood Anxiety Disorders 
Anxiety disorders are one of the most common psychological problems in 
childhood and adolescence (Beesdo, Knappe, & Pine, 2009). Anxiety can be 
characterized as an emotional sense of fear or worry, typically in response to a situation 
or object (Barlow, 2000). Anxiety is prevalent in individuals from birth and is often a 
natural, adaptive response to dangerous or threatening situations (Beesdo et al., 2009). 
Anxiety becomes problematic when the reactions are maladaptive given the 
circumstances (Spiegler & Guevremont, 2010). Excessive anxiety can interfere with a 
child’s ability to function in school, at home, or in social situations. More than 25% of 
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adolescents between the ages of 13 and 18 years suffer from anxiety disorder within their 
lifetime (Anxiety and Depression Association of America, 2017). Furthermore, within 1 
year, approximately 13% of children meet criteria for an anxiety disorder (Wilmhurst, 
2015). Anxiety disorders are typically more prevalent in female individuals (30% lifetime 
prevalence) than male individuals (20% prevalence; National Institute of Mental Health, 
2017). Anxiety disorders may be caused by multiple factors, including genetics, 
psychobiology, and conditioning (Beesdo et al., 2009). Symptoms may present as 
physical sensations, thoughts of negative outcomes, and avoidance of anxiety-provoking 
situations (Barlow, 2000).  
 Some childhood anxiety is developmentally appropriate in response to specific 
situations and events (Beesdo et al., 2009). Most children experience mild levels of 
anxiety and often have anxious responses when faced with such situations as separation 
from parents, unfamiliar animals, or school and performance situations (Beesdo et al., 
2009). This developmental anxiety  can make differentiating normal and maladaptive 
anxiety in children difficult. Despite being developmentally normal, anxiety can still be 
distressing for individuals; infants may cry when separated from their parents, and 
children may feel ill when asked to read a report in front of the class (Beesdo et al., 
2009). However, most children naturally learn to adapt to new and anxiety-provoking 
situations as they age.  
 Anxiety becomes a disorder rather than just a symptom when it meets the criteria 
in the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5; American 
Psychiatric Association [APA], 2013). Children with anxiety disorders experience 
moderate to intense fear or worries, often resulting in significant distress or excessive 
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avoidance of the anxiety-inducing situation (Crozier, Gillihan, & Powers, 2011). Fears 
often revolve around a central theme, including specific items, separation worries, or 
worries of negative perception (Crozier et al., 2011). However, at times, these worries 
can be more general and encompass many themes within a short amount of time (e.g., 
safety, future worries, academic worries).  
The most common anxiety disorders in children are SAD, specific phobias (e.g., 
animal, natural environment, blood-injection-injury, situational), GAD, and panic 
disorder (PD; Crozier et al., 2011). While these disorders may have overlapping 
symptoms and presentations, differential diagnosis of anxiety disorders in children can be 
determined by understanding the central theme of the worries (Crozier et al., 2011). 
Characteristically, anxiety disorders have two common symptoms: avoidance of anxiety-
producing situations and significant cognitive or physical distress. Additionally, anxiety 
disorders significantly interfere with the individual’s functioning at home, school, or in 
social situations (Cohen et al., 2011).  
 SAD is an anxiety disorder unique to childhood (Crozier et al., 2011). Children 
affected by SAD are often anxious about being separated from a caregiver (APA, 2013). 
They may worry about something frightening happening to the caregiver (e.g., accident, 
death) or themselves (e.g., kidnapping, injury) when separated. Children with SAD may 
experience school refusal or tantrums in response to situations in which they may be 
separated from the caregiver (APA, 2013; Crozier et al., 2011). Children may also have 
difficulty spending time with friends or going to sleepovers. Furthermore, this fear is out 
of proportion to the likelihood of occurrence (e.g., parent has never been in a car 
accident, but the child fears one will happen; Crozier et al., 2011). SAD is most prevalent 
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in younger children, with approximately 1.9% of children presenting with this diagnosis 
every year (APA, 2013). However, the rate of SAD diagnoses decreases as children grow 
older. Childhood asthma may increase the likelihood of developing separation concerns, 
as children with asthma and anxiety may worry about an attack occurring when separated 
from their parents.  
 Another type of anxiety disorder commonly found in children is GAD (APA, 
2013). This disorder is characterized by excessive and persistent worrying that is difficult 
to control (APA, 2013). Children may worry about their performance in school, 
something happening to their family (e.g., divorce), safety concerns (e.g., burglaries, 
natural disasters), and new situations or a change in plans. According to diagnostic 
criteria, children also must be experiencing at least one physical symptom (e.g., muscle 
tension, sleep disturbance, headaches). However, many children with GAD experience a 
wide variety of physical symptoms, including shakiness, restlessness, and racing hearts 
(Cohen, Mychailyszyn, Settipani, Crawley, & Kendall, 2011). GAD is prevalent in 
approximately 3% of individuals, but decreases in adolescence (0.9%; APA, 2013). 
Asthma may be a risk factor for GAD, as children with asthma may learn to worry about 
their overall safety, their health, and the impact asthma has on their lives.  
 PD is another anxiety disorder that may occur in childhood, though diagnosis is 
often in late childhood or early adolescence (APA, 2013). Panic disorder results from 
unexpected and recurrent panic attacks, which are characterized by four or more physical 
symptoms. Symptoms include racing heart, stomachaches, hyperventilation, sweating, 
shaking, and dizziness among many others (APA, 2013). Children with PD often develop 
a fear of these panic attacks occurring and may avoid situations that could trigger their 
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panic attacks or places they would be unable to seek help if they had a panic attack (e.g., 
public transportation). PD rates are lower in younger children (less than 0.4%) but 
increase in adolescence, with a yearly prevalence rate of 2 to 3%. However, panic attacks 
may still occur in early childhood. Asthma symptom training may increase anxiety 
sensitivity and overperception of physical symptoms, potentially increasing the risk of 
children developing PD.   
 As previously noted, two major symptoms are prevalent across anxiety disorders: 
the avoidance or intense fear reaction in response to the provoking stimuli and physical 
symptoms. According to Barlow (2000), the level of avoidance depends on the intensity 
of anxiety when presented with cues or triggers. Therefore, children with anxiety 
disorders either avoid the anxiety-provoking situations or endure them with extreme 
duress (APA, 2013). Endurance may include avoidance as well by not attending to the 
anxiety stimulus (e.g., closing one’s eyes). Children may avoid school, where social 
evaluation situations may occur, or when they are not prepared for a project or exam.  
Children may avoid dances, parties, and camps because of separation concerns or fear of 
evaluation from peers. Additionally, new situations may be handled with intense anxiety, 
as children may worry about what is going to happen. Furthermore, clinicians theorize 
that children with GAD may use their constant worrying as a form of avoidance (Cohen 
et al., 2011). Avoidance may also present as somatic complaints, such as stomach aches, 
nausea, or muscle tension (APA, 2013; Crozier et al., 2011).   
 Another common symptom of anxiety disorders is the presentation of somatic 
symptoms. Somatic symptoms are especially prevalent in children suffering from anxiety 
disorders (Cohen et al., 2011). These children often experience physical complaints, such 
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as headaches, muscle tension, restlessness, and stomachaches. Physical symptoms are 
often linked to increase anxiety sensitivity and impairment in children with anxiety 
disorders (Cohen et al., 2011). Children may misinterpret their physical symptoms, 
thinking that something more serious than anxiety is occurring (Pilecki & McKay, 2011). 
Physical symptoms appear to vary based on the child presentating with anxiety, but their 
presence remains consistent across diagnoses (Cohen et al., 2011), making differentiating 
anxiety disorders based on physical symptoms alone difficult. Research has shown that 
children with GAD, social phobia, and SAD exhibit the same frequency of somatic 
complaints despite their different themes in worries (Hofflich, Hughes, & Kendall, 2006). 
As such, manualized treatments targeting somatic symptoms may be effective in reducing 
physical symptoms across anxiety disorders.  
Biological and Natural Causes of Anxiety Disorders 
 While anxiety is caused by a multitude of factors, genetics and biological etiology 
can contribute to the development of anxiety disorders in children. Decades of research 
demonstrate that many individuals who develop anxiety disorders have a biological 
vulnerability to anxiety (Barlow, 2000; Beesdo et al., 2009). Anxiety may also be the 
result of neurological abnormalities emergent throughout developmental periods (Jacob, 
Thomassin, Morelen, & Suveg, 2011). Furthermore, anxiety may be related to different 
temperamental factors present at birth (Winter & Bienvenu, 2011). While none of these 
factors singlehandedly leads to an anxiety in children, the role they play in the 
development of anxiety should be considered.  
Genetic vulnerabilities for anxiety. Anxiety disorders in children appear to be 
related to parental psychopathology (Beesdo et al., 2009). Specifically, children are at 
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increased risk for an anxiety disorder when both parents are coping with anxiety. 
Additionally, children with a strong genetic component may be at risk for early onset of 
anxiety (Arnold & Taillefer, 2011). Despite this heritability, determining the specific 
gene that is linked to the development of an anxiety disorder is difficult. Instead, multiple 
genes interact with the environment to increase the likelihood of an anxiety disorder in 
children (Arnold & Taillefer, 2011).  
Genes alone, however, do not determine whether an individual will develop an 
anxiety disorder (Arnold & Taillefer, 2011; Beesdo et al., 2009). Twin studies have 
demonstrated that while the heritability for genetic anxiety is moderate, variance in 
symptoms is better explained by environmental factors (Beesdo et al., 2009). Therefore, 
anxiety does not have a single genetic cause, but is the result of a relationship between 
genetic make-up and environmental factors. These interactions may also result in the 
abnormal development of various brain structures associated with anxiety disorders.   
Neurological and biological differences in anxiety. Many variations in brain 
structure and functioning are present across anxiety disorders in children (Larson, South, 
& Merkley, 2011). Children with anxiety may demonstrate differences in the size and 
neural connections between brain structures (Beesdo et al., 2009; Jacob et al., 2011; 
Larson et al., 2011). Additionally, other biological processes, including the hypothalamic, 
pituitary, adrenocortical (HPA) axis, may play a role in the onset of anxiety symptoms 
within the body. When stressful life events occur, the HPA axis triggers the release of 
cortisol, a stress hormone, into the bloodstream (Faravelli et al., 2012). While HPA axis 
activity is normal and necessary for fight-or-flight responses in humans, excess stress can 
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result in increased activity in the HPA axis. These stressors may result in HPA axis 
hyperactivity in some children.  
The most common brain region implicated in anxiety disorders is the amygdala 
(Beesdo et al., 2009; Larson et al., 2011). The amygdala is often associated with fear and 
is involved in triggering the fight-or-flight system in response to threatening stimuli. 
Additionally, the amygdala is involved in various steps of the learning process; 
neuroimaging research has demonstrated the amygdala’s involvement in learning to 
associate fear with neutral objects and in the amygdala-frontal cortex connection in the 
extinction process of learning (Beesdo et al., 2009). While the amygdala is a functional 
component of all humans, some research has demonstrated that it may be more active in 
children with anxiety. Increased amygdala activity is also associated with inhibition in 
adolescents (Beesdo et al., 2009).  
In addition to the amygdala, other brain structures and connections may play a 
role in anxiety symptoms (Larson et al., 2011). Children with anxiety may demonstrate 
abnormalities in the hippocampus, anterior cingulate cortex, insular cortex, orbitofrontal 
cortex, and prefrontal cortex. As a result, anxiety may be associated with difficulties in 
executive functioning, memory, and attention. Children with anxiety disorders may have 
difficulty focusing and shifting attention because of their preoccupation with anxious 
thoughts. Memories may be affected by anxious emotions. Children with anxiety have 
also shown difficulty with concentrating, planning, and organizing information as a result 
of their anxious thoughts (Gualtieri & Morgan, 2008). 
Additionally, children with social phobia may demonstrate abnormalities in the 
basal ganglia, medial temporal lobe, and orbitofrontal cortex (Larson et al., 2011). These 
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children may demonstrate some motor delays or language issues in addition to anxiety. 
Children with GAD demonstrate deficits in the superior temporal gyrus and temporal 
lobe. Deficits, specifically within verbal abilities, complex attention, and delayed 
memory, may be detectible using neuropsychological functioning. In addition to these 
neurological differences in anxious children, temperament can play a role in a child’s 
susceptibility to developing pathological anxiety.  
Temperament and anxiety. Temperament can generally be understood as an 
individual’s response pattern to emotional or environmental stimuli (Winter & Bienvenu, 
2011). Temperament often remains stable over time, from infancy to adulthood. In fact, 
temperament is thought of as a precursor to personality development. Most theoretical 
models of temperament describe four specific components: emotionality, extraversion, 
activity, and persistence (De Pauw & Mervielde, 2010).  Emotionality refers to a child’s 
experience of different emotions, including, but not limited to, negative affectivity. 
Extraversion describes the child’s social capacity and social inhibition. Activity 
specifically references a child’s physical-activity levels. Finally, persistence indicates a 
child’s determination and encompasses such concepts as effortful control.  
Specific temperamental traits have been linked to later development of anxiety in 
children. Behavioral inhibition, a specific temperamental style, is characterized by high 
inhibition, high emotionality, and hypervigilant attention to the environment (Degnan, 
Almas, & Fox, 2010). Children with behavioral inhibition may also demonstrate 
behavioral restraint, especially around unfamiliar people, situations, or events (Pahl et al., 
2012).  Specifically in toddlers, behavioral inhibition may present as withdrawal from the 
environment (Jacob et al., 2011). Extreme inhibition is associated with the development 
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of anxiety disorders (Jacob et al., 2011), while approximately 15% of behaviorally 
inhibited children continue to develop normally without any psychopathology (Pahl et al., 
2012).  
In a study conducted by Pahl et al. (2012), researchers discovered that higher rates 
of behavioral inhibition in early childhood predicted higher levels of anxiety. While not 
all children with behavioral inhibition will develop anxiety, many of the traits overlap 
with anxiety symptoms. Inhibition may reflect avoidance in certain unfamiliar or anxiety-
provoking situations. However, environmental factors may influence the effect of 
behavioral inhibition on later anxiety development (Pahl et al., 2012).  
Environmental Etiology of Anxiety 
Parental factors and anxiety etiology. Several parental factors, including family 
stress, parental psychopathology, and parental accommodation, have been identified that 
contribute to the etiology of anxiety disorders (Pahl et al., 2012; Thompson-Hollands et 
al., 2014). Parental and family stress involve various events and situations that may 
burden the family or child (Pahl et al., 2012). These situations may vary from specific 
traumatic events, such as a death, to daily stressors, such as financial problems. 
Additionally, research has demonstrated that parental stress can negatively impact the 
outcome of anxiety treatment for children (Crawford & Manassis, 2001). Parental stress 
may also be related to a parent’s own psychopathology.  
Parental psychopathology can also increase the prevalence of anxiety disorders in 
children (Pahl et al., 2012). Parental psychopathology can affect the ability to cope, 
problem solve, and parent effectively (Pahl et al., 2012; Sales et al., 2008). Parents 
struggling with their own anxiety may use more avoidant coping styles, increasing their 
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own and their child’s anxiety around certain situations or stimuli (Sales et al., 2008). 
Parental anxiety may also result in anxious parenting styles, potentially acting as a social 
or informational learning model for later childhood anxious responses.  
 Parental accommodation has recently evolved as a significant factor in childhood 
anxiety development and maintenance (Lebowitz et al., 2013; Thompson-Hollands et al., 
2014). Parents often intervene when their children are in distress, which is a natural and 
protective response for many parents. However, parental involvement many sometimes 
interfere with a child’s ability to learn new associations regarding anxious situations and 
stimuli (Thompson-Hollands et al., 2014). With anxiety disorders, parents may intervene 
when their children exhibit physical anxious symptoms, helping their children avoid these 
anxiety-provoking situations. Parents may change their own behaviors to ensure their 
children’s anxiety is reduced (Lebowitz et al., 2013); for example, they may quit their 
jobs or avoid certain places (e.g., long vacations requiring use of an airplane for 
transportation). However, because the children are unable to learn that they can tolerate 
their anxiety or that the situation may not be dangerous because of this avoidance, 
parental accommodation can increase anxiety severity in children (Lebowtiz et al., 2013). 
Clinicians may benefit by approaching asthma and anxiety conceptualization from a 
developmental perspective, including the possibility of parental psychopathology and 
accommodation as facilitating factors that work in combination with other environmental 
and biological characteristics.  
Cognitive vulnerability and childhood anxiety. According to the cognitive 
model, one’s thoughts affect one’s emotions, thereby affecting one’s behaviors (Beck, 
1967). This theory holds true in both children and adults. As children experience various 
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situations throughout their development, automatic thoughts arise, leading to potentially 
anxious emotions. Children with specific cognitive vulnerabilities are more susceptible to 
developing anxiety disorders than other children (Hong, Lee, Tsai, & Tan, 2017). 
Intolerance of uncertainty, fear of negative evaluation, and anxiety sensitivity may aid in 
the development of anxiety disorders in children. While these vulnerabilities alone may 
be risk factors for anxiety in children, the interaction of vulnerabilities may lead to 
increased anxiety (Hong et al., 2017). Negative self-talk and anxiety sensitivity are two 
prominent cognitive vulnerabilities found in children at risk for anxiety disorders.  
Negative self-talk. Negative self-talk and negative self-statements are associated 
with higher levels of anxiety (Treadwell & Kendall, 1996). Children with increased 
negative self-talk have demonstrated lower psychological adjustment (Treadwell & 
Kendall, 1996). Even in normal controls, higher reports of anxious self-talk are 
associated with higher reports of anxiety symptoms (Muris, Merckelbach, Mayer, & 
Snieder, 1998). In a study conducted by Muris et al. (1998), negative self-talk was found 
to be positively correlated with anxiety symptoms. Children with more negative self-talk 
and less positive self-talk are especially more likely to report anxiety symptoms (Sood & 
Kendall, 2007). Self-reports of negative self-talk are responsive to anxiety treatment 
(Kendall et al., 2016; Peris et al., 2015; Treadwell & Kendall, 1996); however, higher 
levels of negative self-talk are associated with less favorable treatment outcomes (Muris 
et al., 1998). 
Negative self-talk in children with anxiety is typically specific to their fears and 
worries (Muris et al., 1998; Sood & Kendall, 2007). For example, a child with GAD may 
have increased negative self-talk regarding academic performance or thoughts of failure. 
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Researchers have demonstrated that children with anxiety often worry about social 
situations, academic performance, and their families’ and friends’ well-being (Weems, 
Silverman, & La Greca, 2000), correlating with symptoms of GAD, SAD, and panic 
disorder (Muris et al., 1998). Overall, the content of the self-talk of children with anxiety 
can potentially increase anxious symptoms.  
Anxiety sensitivity. Anxiety sensitivity is the cognitive appraisal of physical 
symptoms as dangerous or harmful (Muris et al., 2010). Children with anxiety sensitivity 
may perceive their physiological symptoms as having severe psychological 
consequences, such as humiliation or losing control. Anxiety sensitivity is associated 
with increased anxiety symptoms, especially panic-related symptoms (Viana et al., 2017). 
Additionally, anxiety sensitivity is related to higher levels of behavioral inhibition and 
negative affectivity.  Viana et al. (2017) found that elevation among anxiety sensitivity 
and temperamental predispositions for anxiety may affect the cognitions associated with 
physical anxiety symptoms.  
Children reporting anxiety sensitivity may be specifically vulnerable to 
developing anxiety disorders (Dia & Bradshaw, 2008), as they learn to fear their own 
body arousal and psychological sensations (McNally 2002; Reiss & McNally, 1985). 
Children with anxiety sensitivity perceive these sensations as potentially having negative 
consequences, including physical problems and social embarrassment (McLeish, Luberto, 
& O’Bryan, 2016). Anxiety sensitivity represents an underlying fear associated with 
many different anxiety disorders (McNally, 2002). As children develop a fear of their 
physical symptoms, they may increase their risk of various anxiety disorders based on the 
situations in which these physical symptoms are experienced.  
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 Anxiety sensitivity differs from negative self-talk in that it consists of four factors 
that may contribute to and fuel a child’s fears (Silverman, Goedhart, Barrett, & Turner, 
2003). Children with anxiety sensitivity worry that something is wrong with them 
mentally. They also worry that their somatic symptoms may represent a harmful physical 
disease or sickness. These children further worry that their various symptoms may make 
them physically weak. Finally, children may worry that others will be able to perceive 
their physical symptoms or anxiety.  These four factors may be present together, 
separately, or in a variety of combinations, potentially leading to various anxiety 
disorders.  
 Researchers have demonstrated that children with anxiety sensitivity have a 
greater risk of developing anxiety disorders (Dia & Bradshaw, 2008). Anxiety sensitivity 
is especially elevated in individuals with PD (Craske & Barlow, 2014), as children may 
associate their physical symptoms with a loss of control, going “crazy,” or a significant 
illness. In a study conducted by Dia and Bradshaw (2008), researchers examined the 
relationship between anxiety disorders and anxiety sensitivity in 185 adolescents 
receiving treatment for an anxiety disorder. Dia and Bradshaw (2008) demonstrated that 
these four factors of anxiety sensitivity were associated with different anxiety disorders. 
GAD in adolescents was associated with concerns of mental well-being, while social 
anxiety was associated with fear of social perception regarding their anxiety. 
Additionally, PD was associated with disease concerns and concerns about feeling weak. 
Disease concerns also predicted increased SAD (Dia & Bradshaw, 2008). Thus far, the 
research suggests that children’s perceptions of their own bodily sensations can shape 
their future psychopathology.  
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 Anxiety sensitivity may explain how some children develop anxiety disorders 
while others are able to move past developmentally normal anxiety. All children 
experience physical symptoms of anxiety at some point, yet the response to their 
symptoms varies from child to child (McNally, 2002). Research has demonstrated that 
anxiety sensitivity may predispose children to develop pathological levels of anxiety 
when experiencing physical symptoms in certain situations (e.g., when performing in 
front of others, when separating from a caregiver; McNally, 2002); however, more 
research is needed to determine the role anxiety sensitivity may play in anxiety 
comorbidity with medical illnesses.   
Implications of Asthma and Anxiety Comorbidity 
 The co-occurrence of anxiety and asthma is associated with many severe medical 
and psychosocial consequences. Anxiety disorders are positively correlated with asthma 
severity (Farrell et al., 2011). While more research is needed to understand these 
correlations, researchers have hypothesized that the consequences of unmaintained 
asthma may increase anxiety (Farrell et al., 2011). Additionally, comorbidity of anxiety 
and asthma increases complications associated with asthma, possibly resulting from the 
association of anxiety with poor asthma control (Roy-Byrne et al., 2008). Comorbidity is 
specifically associated with increased use of healthcare services and an overall increase in 
the cost of healthcare. Children with asthma and anxiety are more likely to use the 
emergency room and be hospitalized for their asthma. Anxiety and asthma are related to 
increased school absenteeism (Farrell et al., 2011), as these children may miss school as a 
result of hospitalization and healthcare use.  
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 School absenteeism and asthma severity can also contribute to impaired QOL in 
children with comorbid anxiety and asthma. In a study conducted by Vila et al. (2003), 
researchers found that comorbid asthma and internalizing psychological problems 
accounted for decreases in QOL in adolescents. Additionally, researchers demonstrated 
that QOL was negatively affected by children’s limitations in activity (Vila et al., 2003). 
This negative effect may result from disruptions in interacting with peers or participating 
in age-normative activities. Children with asthma may have difficulty engaging and 
interacting with peers, potentially resulting in anxiety in social situations or low self-
esteem.  
 Anxiety sensitivity and attentional bias may have a negative effect on asthma 
control. Given the intention of action plans and symptom perception training, children 
with asthma are educated to become more perceptive of their physical symptoms to 
increase awareness of potential asthma exacerbations (Farrell et al., 2011). As a result, 
children with asthma may read symptoms, such as an increased heart rate or difficulty 
breathing, as early signs of an asthma exacerbation, despite no physiological cause for 
these symptoms. Anxiety sensitivity and attentional bias may increase the chances of 
developing anxiety disorders in children with asthma. Additionally, these characteristics 
may contribute to the generalization of learning from certain situations and triggers to 
broader contexts that might trigger an asthma exacerbation. For example, children who 
are often triggered by pet dander may develop anxiety symptoms whenever they see an 
animal from a distance. 
Characteristics of Children with Anxiety and Asthma 
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  As previously mentioned, certain childhood characteristics may predispose 
children to developing anxiety. Given the high comorbidity between anxiety and asthma, 
researchers have examined various characteristics within these children that may increase 
their likelihood of developing anxiety. Additionally, some of these factors may interfere 
with psychological and medical treatment for asthma and anxiety. Table 2 summarizes 
the literature outlining anxiety sensitivity, health worries, attentional biases, and negative 
self-talk in individuals with asthma and anxiety.  
 Patients with asthma may have an attentional bias toward their symptoms and any 
cues that remind them of an asthma exacerbation (Dudney et al., 2017; Lowther et al., 
2016). Parental anxiety has also been shown to increase these attentional biases children 
have regarding their asthma symptoms (Lowther et al., 2016). This attentional bias may 
increase a child’s perception of actual asthma symptoms or asthma-like somatic 
symptoms, potentially causing him or her to overlearn a fear response toward somatic 
symptoms. Furthermore, attentional bias toward asthma symptoms may be a learned 
response from observing parents’ fear reactions regarding airway constriction concerns. 
 Children with asthma and anxiety may also exhibit anxiety sensitivity in response 
to their various physical symptoms (McLeish et al., 2016). Children with anxiety 
sensitivity are more likely to view their asthma symptoms negatively, possibly leading to 
the misinterpretation of potential panic-like symptoms as something more medically 
related (Carr, Lehrer, Rausch, & Hochron, 1994). Thus, anxiety sensitivity is likely to 
predispose patients with asthma to increased and unnecessary panic attacks. Anxiety 
sensitivity in patients with asthma was also related to poor asthma control (McLeish et 
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al., 2016). Anxiety responses may increase their reactivity to asthma-like symptoms, 
potentially decreasing their ability to adaptively cope to both panic and asthma attacks.  
Table 2 
Literature Summary of Psychological Characteristics of Anxiety and Asthma 
Articles Sample Research outcomes 
Dudeney et al., 2017 Children aged 8-13 
years; asthma and 
anxiety group 
compared with 
anxiety only group 
Poor asthma control was associated with 
increased attentional biases toward asthma-
like symptoms. 
Lowther et al., 2015 Children between 9-
12 years old; asthma 
group compared with 
nonasthma group 
Children with asthma demonstrated an 
attentional bias toward asthma-like words, 
but not any other negative words. Children 
in the asthma group had higher rates of 
caregiver anxiety than children without 
asthma. Higher paternal anxiety was 
associated with increased attentional bias in 
children with asthma. 
Rietveld & Brosschet, 
1999 
Literature review Children may experience increased negative 
self-talk during asthmatic exacerbations, 
potentially leading them to experience 
panic.  
McLeish et al., 2010 Adults with asthma Fear of asthma symptoms related to anxiety 
sensitivity was linked to decreased asthma 
control. 
McLeish et al., 2016 Undergraduate 
students with asthma 
Increased anxiety sensitivity was associated 
with decreased lung functioning, indicating 
that individuals with asthma and anxiety 
may have increased reactivity to asthma 
symptoms.  
Lind et al., 2014 Adults with various 
allergic and 
Allergic asthma was more likely to be 
associated with anxiety than nonallergic 
asthma. Increased health worries in these 
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nonallergic medical 
conditions 
individuals were more likely to be 
associated with increased anxiety.  
Carr et al., 1994 Adults with and 
without asthma 
Panic attacks are more common among 
individuals with negative cognitions 
regarding their somatic symptoms 
regardless of asthma diagnosis. Individuals 
with asthma and panic disorder were more 
likely to have more catastrophic beliefs and 
negative cognitions regarding body 
sensations than individuals without asthma.  
Avallone et al., 2012 Adults from an 
asthma and allergy 
clinic 
Anxiety sensitivity of physical sensations 
predicted worse asthma control, increased 
asthma symptoms, lower emotional 
function, and a greater effect of 
environmental stimuli on symptoms.  
Feldman et al., 2010 Puerto Rican parents 
and their children  
Parental psychopathology was associated 
with higher rates of anxiety and asthma 
comorbidity. These rates of parental 
psychopathology were not demonstrated 
with children with depression.  
Wamboldt et al., 1995 Children with asthma 
and their parents 
Children with severe, chronic asthma were 
more likely to have a parent with a history 
of trauma than children without asthma. 
This trauma history was associated with 
increased parental emotional distress and 
psychopathology. Parental trauma was also 
associated with child psychopathology.  
 
The literature further examines the role of negative cognitions on higher rates of 
anxiety and asthma comorbidity. Individuals with both anxiety and asthma demonstrate 
greater health worries and negative cognitions regarding their somatic presentations than 
children with asthma alone (Carr et al., 1994; Lind et al., 2014). Specifically, their 
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cognitions were more likely to be catastrophic in response to asthma-like symptoms. 
While children with comorbid asthma and anxiety may still exhibit increased negative 
self-talk, the content of this self-talk may be different from that of anxious children 
without a medical comorbidity. Children with comorbid asthma and anxiety may focus 
more on their health-related worries and less on other worries that typically accompany 
anxiety disorders (e.g., school, social situations; Lind et al., 2014).    
Findings also demonstrate the potential relationship between parental 
psychopathology and increased asthma and anxiety. Children of parents with a history or 
current presentation of psychological distress were more likely to have an anxiety 
disorder themselves when compared to other developing children (Feldman et al., 2010; 
Wamboldt et al., 1995). In some cases, childhood illness may act as a trigger for parental 
psychopathology, potentially leading to retraumatization (Wamboldt et al., 1995). While 
parental psychopathology apparently affects the development of childhood anxiety and 
the medical trajectory of asthma, more information is needed to understand the 
interaction between genetics, parental modeling, and vicarious learning.  
Overall, findings demonstrate that a relationship may exist between anxiety 
sensitivity and the role cognitions play on the presentation and development of an asthma 
and anxiety comorbidity. Anxiety sensitivity has many negative effects on asthma 
functioning and should be addressed in treatment of children with asthma and anxiety 
comorbidity. Additionally, negative self-talk may present with a larger focus on health-
related worries in this population, again showing the need to specifically address the 
different content of these worries in treatment. However, more research is needed to 
further understand how these characteristics may present in children with an asthma and 
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anxiety comorbidity, as much of the research so far has been conducted only on adults.  
Additionally, more research is needed to understand how anxiety sensitivity and negative 
self-talk in asthma and anxiety comorbidities may affect treatment protocols for this 
population.  
Classical Conditioning and Anxiety Acquisition  
One of the most commonly studied methods of behavioral learning is classical 
conditioning, also known as Pavlovian conditioning. According to classical conditioning 
theory, individuals learn to perform a conditioned response when a conditioned stimulus 
is presented (Domjan, 2018). This learning is the result of pairing a neutral stimulus with 
a stimulus that elicits a particular response. Specifically, for anxiety, the neutral stimulus 
(e.g., dog) is paired with a previous stimulus (e.g., dog bark) eliciting a fear response 
(e.g., startle). Through repeated pairings of the neutral stimulus and unconditioned 
stimulus, the individual begins to associate the neutral stimulus with the unconditioned 
response. This pairing causes the neutral stimulus to then become a conditioned stimulus, 
creating an association between the conditioned stimulus and conditioned response. After 
sufficient learning, the unconditioned stimulus is no longer needed for the response to 
occur.  
Within specific disorders, fear conditioning is demonstrated to increase avoidance 
or fear response regarding specific triggers, situations, and even body sensations. Within 
panic disorder, individuals learn that specific body sensations (e.g., increased heart rate) 
are associated with an increased sense of danger (Clark & Barlow, 2014). SAD may 
develop in individuals who have previous experiences of adverse social relationships 
(Heimberg & Magee, 2014). For example, bullying in childhood may lead someone to 
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develop a conditioned fear response to social situations. In cases of GAD, individuals 
may learn that the actual act of worrying (e.g., what is going to happen in the future) can 
act as a means of avoiding the present moment (Roemer & Orsillo, 2014). For example, a 
child may worry about her future in college to avoid the present anxiety she may feel 
while taking a test. Overall, conditioning is a major factor in the development of anxiety 
disorders and plays a role in the type of disorder a child may acquire.  
Some research has demonstrated that asthma-related symptoms may also result 
from contextual learning. Children and adults with asthma may develop asthma-like 
somatic symptoms in response to contextual cues versus actual physiological triggers (De 
Peuter et al., 2007; Rietveld & Brosschot, 1999). Rietveld, Van Beest, and Everaerd 
(1999) demonstrated that adolescents can have an asthma exacerbation caused by mental 
stress, yet biological indicators of pulmonary functioning remain normal throughout the 
attack. Additionally, many studies have demonstrated that asthma symptoms can increase 
when individuals are presented with a placebo asthma drug (De Peuter et al., 2007) or 
contextual cues that previously preceded an asthma attack (De Peuter et al., 2007). 
Children and adults may learn to associate various settings, situations, or thoughts with 
their asthma, potentially resulting in an uncued asthma attack. However, more research is 
needed to determine the role that conditioning and contextual learning have in asthma 
attacks.  
 Rachman (1977) proposed several limitations to the explanation of classical 
conditioning in fear acquisition. First, classical conditioning does not explain why some 
potentially fear-inducing situations do not result in learned anxiety or fear. For example, 
traumatic situations may not result in classical conditioning of neutral stimuli despite 
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repeated and intense exposure. Second, classical conditioning is not easily produced in 
humans in a laboratory setting. Although examples such as Little Albert (Watson & 
Rayner, 1920) exist, other research has demonstrated that creating long-lasting fears in 
humans is difficult in a laboratory setting. Third, classical conditioning research has not 
demonstrated the equipotentiality premise. That is, not all neutral stimuli are likely to 
become conditioned fear stimuli. Instead, conditioning is more likely to occur when the 
stimuli have a stronger biological significance (e.g., fear of dogs vs. fear of glasses). 
Fourth, classical conditioning does not account for the distribution of fears. Specifically, 
some fears are too common or too rare to be attributed to classical conditioning alone. 
Fifth, many individuals are unable to report a significant event or situation that is 
associated with the onset of their fear. As such, fear onset is difficult to attribute to 
classical conditioning alone. Finally, classical conditioning does not take into account 
vicarious transmission of fears. Individuals may develop anxiety or fears based on 
modeling and fear reactions from others. To address these limitations, Rachman (1977) 
updated the theory to include the transmission of information and vicarious acquisition of 
trauma. 
Rachman’s Model of Anxiety  
Rachman proposed an expansion of the classical conditioning theory to address 
the limitations of the conditioning theory in explaining the development of anxiety 
disorders in children. While the classical conditioning theory is helpful in explaining 
many ways anxiety can formulate in children, it fails to explain the acquisition of fear or 
failure to develop fear in certain situations (Rachman, 1977). More so, classical 
conditioning is not enough for individuals to associate seemingly neutral stimuli as 
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fearful or anxiety provoking (McLeod et al., 2011). Therefore, Rachman (1977) 
developed an alternative theory that elaborated on other ways children may develop 
anxiety.  
 While still acknowledging the importance of conditioning on the development of 
anxiety, Rachman (1977) recommended two additional explanations for anxiety 
development in children. First, children may develop fears from the transformation of 
information, or instruction-based learning (McCleod et al., 2011; Rachman, 1977). A 
child may develop a fear of strangers after a mother warns her child time and again of the 
potential dangers of strangers. Second, children may develop anxiety based on vicarious 
transmission of fears (McCleod et al., 2011; Rachman, 1977). Children develop fears 
because their parents model anxious behaviors. In this case, children may hear their 
parents verbalize their own anxious self-talk when separating from their child. Overall, 
these additions to conditioning theory are helpful in explaining why children may acquire 
fears despite not having direct exposure to the feared stimulus (Rachman, 1977). A 
similar theoretical approach can be used to explain why some children with asthma 
develop physical symptoms without a biological explanation.  
Parental psychopathology, specifically health anxiety, has been shown to increase 
children’s own anxiety regarding their health (Marshall, Jones, Ramchandani, Stein, & 
Bass, 2007; Wright et al., 2017). Findings from Wright et al. (2017) demonstrated that 
parental depression and health anxiety are linked to increased health anxiety in their 
children. This association may be the result of parental modeling or informational 
learning; children learn that physical sensations and illness are to be feared because of 
their own parents’ fears. Additionally, Marshall et al. (2007) compared the cognitions of 
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children with medically ill parents and those of children with a parent diagnosed with 
somatoform disorder. Findings exhibited that children of parents with a psychological 
illness scored higher on negative health cognitions, with increased fear of body 
sensations (Marshall et al., 2007). While these studies on parental psychopathology and 
its effects on child health anxiety are just preliminary, they demonstrate the potential 
impact that parental modeling may have on anxiety acquisition in children.  
As previously stated, while classical conditioning can explain some aspects of 
anxiety and asthma development, other learning styles should be examined as potential 
causes of increased anxiety and asthma exacerbations (Rachman, 1977). Children with 
both anxiety and asthma may develop increased symptoms as a result of modeling and 
vicarious learning, typically from their parents. With asthma, children who have parents 
with more emotional difficulties demonstrate lower asthma functioning and increased 
internalizing symptoms (Al Ghriwati, Winter, Everhart, & Fiese, 2017). Furthermore, 
families associated with more positive problem-solving capabilities and increased 
functioning were associated with decreased internalizing psychopathology in children 
with asthma (Al Ghriwati et al., 2017).  This association may be the result of learning 
from the parent’s own fears and anxiety regarding the child’s medical condition.  
Whether this learning is the result of modeling or vicarious-information processing is 
unclear; however,  the significance of family emotionality on childhood asthma and 
anxiety functioning should be noted.  
Treatment of Childhood Anxiety and Asthma 
Anxiety Disorders 
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Cognitive-behavioral therapy (CBT) has shown to be effective in treating anxiety 
disorders in children (Kendall et al., 2016). CBT has shown to decrease physiological 
symptoms and cognitive symptoms and to increase coping skills associated with anxiety 
disorders in children. CBT is also helpful in targeting the maladaptive thoughts 
associated with childhood anxiety by challenging these negative thoughts (e.g., what 
evidence is there that mom will be fine?; Kendall et al., 2016; Peris et al., 2015). Meta-
analyses have demonstrated that CBT for children with anxiety continues to be one of the 
most effective treatment modalities for reducing anxiety symptoms (Crowe & McKay, 
2017; Hofmann, Asnaani, Vonk, Sawyer, & Fang, 2012). Findings from a recent meta-
analysis conducted by Crowe and McKay (2017) supported that CBT is significantly 
more effective than no treatment for anxiety and is the standard treatment for childhood 
anxiety disorders.  
 A meta-analysis conducted by Hofmann et al. (2012) concluded that CBT is the 
preferred treatment for childhood anxiety disorders. One of the most commonly 
implemented CBT protocols for childhood anxiety is the Coping Cat, which was initially 
developed for children with GAD, social phobia, and SAD (Kendall & Hedtke, 2006). 
The Coping Cat integrates cognitive techniques, such as addressing cognitive distortions, 
with behavioral tasks, such as exposure and problem solving. The Coping Cat has 
demonstrated an increase in coping skills and a decrease in reports of distress associated 
with anxiety (Albano & Kendall, 2002; Kendall & Hedtke, 2006). The Coping Cat has 
also demonstrated a reduction in clinical levels of anxiety disorder symptoms (Albano & 
Kendall, 2002). Research further demonstrates that children continue to show positive 
results after a year’s follow-up (Albano & Kendall, 2002). However, cognitive-
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behavioral treatment of anxiety disorders in children has been enhanced by the use of 
medical interventions (Compton et al., 2010).  
 In one of the largest studies researching the efficacy of CBT treatment, 
medication, and combined approaches to anxiety disorders in children, Walkup et al. 
(2008) examined the treatment of 488 children and adolescents with anxiety disorders. 
Children were randomized into four treatment conditions: CBT only, 
psychopharmacology, combined CBT and psychopharmacology treatment, and placebo 
pill treatment. Both the CBT and combined treatment groups used the CBT as a treatment 
protocol, while the psychopharmacology and combined groups were prescribed 
sertraline. Findings demonstrated that while all treatment groups were more effective 
than the placebo pill, the combined CBT and sertraline group showed the most 
improvement after 12 weeks of treatment (Walkup et al., 2008). Recent research has 
demonstrated that CBT remains the front-line treatment for youth with anxiety disorders 
(Silk et al., 2016). Children with anxiety disorders respond to a variety of treatment 
conditions; however, when other complicating factors, such as medical diagnoses, act as 
a potential risk factor, treatment may need to be modified.   
Treating Anxiety and Asthma  
Various cognitive-behavioral treatments have been implemented in pediatric 
populations to treat both medical illnesses and comorbid psychological distress. 
Furthermore, research has demonstrated the success of medical interventions on 
childhood anxiety. Table 3 summarizes the various CBT research that has been 
conducted on anxiety, asthma, and comorbid samples. The research presented in this 
table demonstrates that CBT plus medication and lifestyle management can be effective 
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in treating pediatric populations; however, special considerations should include the 
impact of the medical disorder on psychopathology symptoms.  
Table 3 
Summary of Treatments for Anxiety and Asthma 
Authors Sample Outcome 
Sicouri et al., 2017a Children with 
comorbid anxiety and 
asthma (n = 5) 
Group cognitive –behavioral therapy 
(CBT) for anxiety and asthma 
specifically tailored to the comorbidity 
was effective in reducing anxiety and 
improving asthma-associated quality 
of life. Treatment was effective 
regardless of whether the child's 
asthma and anxiety were related. 
Weersing et al., 2017 Children aged 8-16 
years, recruited from 
pediatric clinics (n = 
185) 
A brief behavioral intervention 
targeting anxiety and depression in a 
pediatric sample was more effective 
than outpatient therapy.  
Papneja et al., 2006 Children aged 8-16 
years, comparing 
comorbid anxiety and 
asthma group with 
anxiety-only group (n = 
36) 
Children with comorbid anxiety and 
asthma showed improvement with 
CBT treatment, but not as much as 
those without a comorbid medical 
diagnosis.  
Feldman et al., 2016 Latino adults with 
asthma (n = 53) 
Individuals in both the cognitive 
behavioral psychophysiological 
therapy (CBPT) group and music 
relaxation therapy group demonstrated 
reduced panic disorder, anxiety, and 
asthma symptoms. The CBPT group 
was associated with better medication 
adherence.  
Ross et al., 2005 Adult women with 
comorbid asthma and 
anxiety (n = 25) 
Women in a CBT group with asthma 
education demonstrated improved 
panic, general anxiety, and anxiety 
sensitivity. However, significant 
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asthma-related improvements were not 
demonstrated.  
Lehrer et al. 2008 Adults with comorbid 
asthma and panic 
disorder (n = 15) 
Adults in both the 14-week and 8-
week treatment (CBT and asthma 
adherence) demonstrated reduced 
asthma symptoms, reduced panic 
symptoms, and increased asthma 
quality of life. Also demonstrated 
reduced use of albuterol.  
 
Researchers are currently exploring effective treatments for asthma and anxiety 
comorbidity. Papneja and Manassis (2006) examined the effects of traditional CBT for 
childhood anxiety on a sample with comorbid asthma and anxiety, comparing this group 
to children with anxiety alone (N = 170). The children in the comorbid group did not 
respond as well to CBT when compared to children with anxiety alone. Given that 
children with asthma did not respond as well to traditional CBT, adaptations to the 
protocol may be necessary to decrease anxiety symptoms and asthma-related 
complications. However, these children were recruited from the general population for 
the treatment of anxiety. While asthma was present in 36 children in the sample, asthma 
was not the primary complaint for these participants.  
In an initial pilot study conducted with five children, Sicouri et al. (2017a) 
implemented a CBT protocol, integrating asthma-related psychoeducation and 
interventions for children with comorbid asthma and anxiety who had their asthma under 
control with medical treatments. In addition to standard CBT techniques (e.g., cognitive 
restructuring, problem solving, exposures), children also received psychoeducation on 
asthma and learned how to differentiate between asthma and anxiety symptoms. Despite 
the small sample size for this study, the adjusted CBT treatment was effective at reducing 
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overall anxiety for all five children, with three of them no longer meeting diagnostic 
criteria. QOL also improved in three of the children and helped increase asthma symptom 
control in two children. However, conclusions regarding the psychological treatment of 
children with asthma and anxiety are severely limited by the small number of studies to 
date. Therefore, an examination of the treatment of adults with asthma and anxiety is 
helpful.  
Adult studies have also suggested that addressing asthma within CBT treatment 
for anxiety can help reduce both anxiety symptoms and asthma symptoms (Feldman et 
al., 2016; Lehrer et al., 2008; Ross et al., 2005). In a pilot study of treatment for PD and 
asthma comorbidity, Lehrer et al. (2008) compared a 14-week asthma and anxiety 
protocol to an 8-week protocol. The 14-week protocol incorporated asthma 
psychoeducation (e.g., peak flow monitoring, use of medications, asthma physiology) and 
asthma-specific CBT techniques (e.g., problem solving, etc.) into a panic treatment based 
on Barlow, Craske, and Meadow’s (2000) panic control therapy. Subjects were provided 
with information regarding cognitive restructuring, problem solving, identifying panic 
symptoms versus asthma symptoms, asthma management, and effective communication 
tools for speaking with medical professionals about their asthma. The 8-week protocol 
was a shortened version of this treatment to address attrition and difficulty with 
recruitment. Findings from this pilot study demonstrated that both protocols were 
effective in reducing panic symptoms, decreasing asthma symptoms, and increasing QOL 
for patients (Lehrer et al., 2008). Despite high attrition rates in this study (i.e., 50% of 
participants dropped from the 14-week protocol), this study sets a foundation for 
addressing both asthma and anxiety in treatment.  
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Further research with adults has demonstrated mixed findings. Integrating asthma 
education into CBT treatment for anxiety may be helpful to individuals with this 
comorbidity. For example, in a study conducted by Feldman et al. (2016), adult 
participants with comorbid asthma and anxiety were treated with a combined CBT and 
heart rate biofeedback treatment condition (i.e., cognitive-behavioral psychophysiological 
therapy; CBPT). This treatment included peak flow monitoring to help differentiate 
asthma and panic symptoms. When compared to a music therapy group, the CBPT 
demonstrated increased medical adherence, although both treatment conditions showed 
equal improvement in panic symptoms.  In addition, a study conducted by Ross et al. 
(2005) demonstrated similar findings. Their CBT protocol was modified again from 
Barlow, Craske, and Meadow’s (2000) PD treatment to include asthma education. This 
adaptation included information on asthma, correct use of asthma medication, peak flow 
education and training, and action plan development. This treatment was effective in 
reducing frequency of panic episodes and in increasing QOL. However, long-term 
maintenance of improvements was not demonstrated at a 6-month follow-up. While this 
study did help reduce panic symptoms in women with comorbid asthma and anxiety, it 
did not demonstrate long-term improvements in anxiety and asthma treatment 
management.  
Current research on adult or child treatment of comorbid asthma and anxiety has 
not demonstrated consistently significant findings regarding the increased efficacy of 
asthma education/CBT treatments for asthma and anxiety. These findings may be related 
to several limitations regarding the current research on effective treatments for asthma 
and anxiety comorbidity. First, many of the studies conducted had small sample sizes 
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(e.g., five children, 15 adults). Consequently, the effectiveness of these treatments is 
difficult to determine for children and adults with comorbid asthma and anxiety. Second, 
not many of these studies have been replicated. While a few studies have demonstrated 
that addressing asthma can be helpful, many do not conceptualize CBT treatment for 
asthma and anxiety in a similar fashion, making difficult the generalization of the results 
to other individuals with this specific comorbidity. Finally, more research is needed using 
a standardized treatment protocol to address consistency across research studies. The 
current research uses different protocols developed by each researcher, thus lacking 
consistency among studies. Thus, e the type of asthma and anxiety treatment that is 
effective in helping individuals with both disorders is difficult to determine.  
Research findings thus far suggest that addressing asthma symptoms in treatment 
is effective in both reducing anxiety symptoms and increasing asthma adherence in the 
short term. These findings may explain that the asthma-related fears are being both 
validated and addressed in treatment. While some worries may be exacerbated by such 
characteristics as anxiety sensitivity, these worries may be grounded in an adaptive need 
to avoid certain triggers (Feldman et al., 2016). Important aspects of asthma treatment 
may incorporate techniques that increase susceptibility to anxious thoughts (Farrell et al., 
2011). For example, symptom perception training may increase awareness of panic-like 
symptoms. However, CBT treatments addressing asthma-related worries can 
acknowledge this threat while reducing any overavoidance of triggers. Additionally, 
psychoeducational components of psychotherapy that specifically involve asthma may 
help patients understand the importance of asthma treatment adherence (Sperry, 2009). 
Asthma psychoeducation alone is not sufficient to increase adherence. Therefore, 
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integration of both asthma and anxiety symptoms into the content of CBT treatment may 
be necessary to help reduce psychological effects and improve physical health.  
However, studies have demonstrated that certain cognitive and behavioral 
techniques typically used for anxiety may not be appropriate for individuals with 
comorbid asthma. For example, interoceptive exposures, such as hyperventilation 
exercises, may be physically dangerous for clients with asthma (Feldman et al., 2016). 
While some researchers have demonstrated that this type of treatment can be safely 
conducted with patients with asthma (Ross et al., 2005), precautions should be taken with 
this specific population to ensure safety. Physician clearance is necessary, and the 
therapist should be cognizant not to introduce the technique too early, so as to reduce 
chances of any medical side effects (Ross et al., 2005). However, the research on 
interoceptive exposure with patients with asthma is limited, and more information is 
needed before this treatment can be introduced as a standard treatment for anxiety and 
asthma comorbidity.  
Further studies are needed to determine the best course of treatment for comorbid 
asthma and anxiety disorders in children. While CBT is considered an extremely 
effective treatment for childhood anxiety (Crowe & McKay, 2017; Hofmann et al., 2012; 
Kendall et al., 2016), more information is needed to demonstrate the benefits of 
incorporating asthma-specific cognitive, behavioral, and psychoeducational components 
into traditional CBT treatments for anxiety. CBT treatment of anxiety alone does not 
address the underlying cause of some of the anxiety symptoms exhibited by children with 
asthma. Children with asthma may have rational hesitancies toward certain triggers, 
leading to an increase in anxiety in situations that may exacerbate asthma symptoms. 
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Additionally, children may be conditioned to interpret physical symptoms as an asthma 
attack, rather than as symptoms of anxiety. By addressing both asthma and anxiety in 
treatment, clinicians may be able to increase adherence to asthma treatment, decrease 
anxiety, and prevent further episodes of both conditions.  
Conclusion 
 Overall, the interaction between anxiety and asthma in children can result in 
severe medical and psychosocial consequences. Children with this comorbidity may have 
lower medical adherence, lower QOL, and increased levels of anxiety than children 
without anxiety. Asthma and anxiety may share similar developmental characteristics, 
such as anxiety sensitivity, presentation of physical symptoms, and the learning 
associated with perceived physical symptoms. Additionally, comorbid asthma and 
anxiety can result in significant impairment in functioning, including increased healthcare 
use and increased symptom presentation for both disorders. Comorbidity between anxiety 
and asthma has been shown to respond to CBT treatments that incorporate asthma 
education and adherence in the protocol. However, traditional CBT treatments do not 
seem to be effective in decreasing anxiety or increasing medical adherence for 
individuals with this comorbidity. Furthermore, current research on psychological 
treatments for anxiety and asthma comorbidity is limited, as the few studies involving 
treatment of this population have smaller sample sizes. Therefore, more information is 
needed to understand how these children differ from their peers with only an anxiety 
diagnosis, specifically from a larger sample of children with asthma and anxiety 
comorbidity. Furthermore, more research is needed to determine if a more integrated 
approach is necessary for treatment of anxiety and asthma.  
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The following study investigated the characteristics of children with asthma and 
anxiety and how asthma may interact with traditional CBT treatment for anxiety. It was 
hypothesized that children with asthma and anxiety would have more physical worries, 
physical symptoms, parental anxiety, panic symptom, generalized anxiety symptoms, and 
separation anxiety symptoms when compared to children with anxiety but without 
asthma. Conversely, the comorbid asthma and anxiety group would have less general 
negative self-talk when compared to children with anxiety without asthma. Additionally, 
it was hypothesized that asthma would be a moderator for treatment between the 
comorbid asthma and anxiety group and the nonmedical anxiety group, with the 
comorbid asthma and anxiety group responding less well to treatment.  This study used a 
larger sample size to address some of the limitations presented in the current research on 
asthma and anxiety treatment. This study hopefully sheds some light on children with 
asthma and anxiety comorbidity and how this combination of disorders may affect 
treatment. 
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CHAPTER 3: METHODS 
 The current study employed an archival, quasiexperimental research design to 
compare characteristics of children with comorbid asthma and anxiety and children with 
anxiety but without a comorbid medical condition. Specifically, the levels of anxiety 
severity, negative self-statements, physical symptom presentation, panic, generalized 
anxiety and separation anxiety symptom presentation, parental anxiety, and theme of 
worried thoughts were compared. Additionally, this study compared the treatment 
response of children with comorbid anxiety and asthma to the treatment response of 
children without comorbid asthma across the four treatment groups.  
Participants 
 Children from ages 7 to 17 years were included in the original data collection 
process of the Childhood Anxiety Multimodal Study (CAMS; Walkup et al., 2008). 
Approximately 488 children were assigned to four treatment groups across multiple sites 
around the United States after initial phone screening and diagnostic assessment. Three 
treatment groups (i.e., cognitive-behavioral therapy [CBT], sertraline, and a combined 
CBT/psychopharmacology group) were compared to a placebo psychopharmacology 
group. Of these participants, 78.9% were white, 49.5% were female, and 74.2% were 
younger than 13 years old. From the original data of 488 participants, 18.1% (n = 88) 
answered yes to Question 25 on the medical questionnaire, indicating a history of asthma 
or asthma-related disorder. These 88 participants were compared to the remaining 400 
participants in the nonasthma group.  
Inclusion Criteria 
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 All children meeting criteria for at least one anxiety disorder were included in the 
data collection of the original study. Specifically, children meeting criteria for primarily 
generalized anxiety disorder (GAD), separation anxiety disorder (SAD), or social phobia 
were included in the study (Walkup et al., 2008).  However, most children received a 
diagnosis of at least two primary anxiety disorders (78.7%) and at least one secondary 
diagnosis (55.3%). For this particular study, children who were marked by parents as 
having asthma were placed in the asthma group, while children whose parents marked 
“no” on this question were placed in the comparison group.  
Exclusion Criteria 
 Children were excluded from the original study if they were diagnosed with an 
unstable medical condition, and girls were excluded if pregnant or sexually active 
without birth control (Walkup et al., 2008). Additionally, children were excluded if they 
previously were involved in two trials for SSRI but had no response or were treated using 
CBT. Furthermore, children were excluded if they were receiving any psychiatric drugs 
other than stimulants or were diagnosed with any psychological disorders that may 
interfere with anxiety treatment. Children were also excluded if they refused school 
because of anxiety or presented a risk to themselves or others.  
Measures 
Demographics 
 Demographic data regarding age, gender, and ethnicity were collected from parent 
participants.  
Screen for Child Anxiety Related Emotional Disorders (SCARED; Birmaher et al., 
1997; Birmaher, Khetarpal, Cully, Brent, &McKenzie, 1999) 
 56 
 The SCARED is a 41-item self-report questionnaire that measures anxiety 
disorders in children. The SCARED has demonstrated ability to indicate high levels of 
anxiety in children and to differentiate among specific anxiety disorders (Birmaher et al., 
1999). Specifically, this measure screens for panic disorder (PD), generalized anxiety 
disorder (GAD), school avoidance (SH), social anxiety (SC), and separation anxiety (SP).  
Children were asked to rate their identification with anxiety statements using a 3-point 
Likert scale (0 = not true or hardly ever true of me; 1 = somewhat true or sometimes true 
of me; 2 = very true or often true of me). Children received an overall score indicating 
their anxiety and five subscores, which were linked to specific anxiety disorders 
previously mentioned. A total score of 25 or greater on the SCARED indicates a potential 
anxiety disorder. The SCARED was used to determine severity of anxiety and different 
anxiety presentations.  
 The SCARED has previously demonstrated strong overall internal consistency (α 
= .90) and internal consistency regarding the five subtests of anxiety ranging from α = 
.78 to α = .87 (Birmaher et al., 1997; Birmaher et al., 1999). The SCARED has also 
shown sufficient discriminant validity when compared to depression measures (Birmaher 
et al., 1997; Birmaher et al., 1999). The SCARED also demonstrates sufficient 
discriminant validity in separating anxiety diagnoses, especially when comparing panic 
disorder (PD) to other anxiety disorders (Birmaher et al., 1997; Birmaher et al., 1999).  
Pediatric Anxiety Rating Scale (PARS; Research Units on Pediatric 
Psychopharmacology Anxiety Study Group, 2002).  
 The PARS measures general child and adolescent anxiety severity, and consists of 
two sections, a symptom checklist and severity scale. The symptom checklist consists of 
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50 items requiring children, parents, and investigators to indicate whether a specific 
anxiety symptom had been present within the past week. Symptoms fall into five 
categories – generalized social interactions or performance situations, separation, specific 
phobia, acute physical signs and symptoms, and other. The severity scale asks 
participants to rate the frequency, severity, avoidance, interference, and number 
associated with anxiety symptoms within the past week. Ratings are done on an 8-point 
Likert scale from 0 (none) to 7 (extreme). The severity scale is then totaled; this measure 
was the primary outcome measure used in the CAMS study. The PARS has demonstrated 
test-retest reliability (r = .55), internal consistency (α = 0.64), and interrater reliability (r 
= 0.97; Research Units on Pediatric Psychopharmacology Anxiety Study Group, 2002).  
Coping Questionnaire – Child (CQ-C; Kendall & Marrs-Garcia, 1999)  
 The CQ-C is a 3-item self-report questionnaire that assesses a child’s sense of his 
or her own ability to cope with distressing situations (Kendall & Marrs-Garcia, 1999). 
The situations are personalized to each child based on parent and child report of worries 
and anxiety-provoking situations. The questions are rated on a scale of 1 (not at all able 
to help myself) to 7 (totally able to help myself). However, for the purpose of this study, 
the content of the worries was examined. Worries and anxious situations were separated 
into six categories (i.e., academic/performance concerns, social/evaluation concerns, 
physical/natural danger, school phobia/refusal, specific fear, and separation concerns). 
The CQ-C has demonstrated test-retest reliability and is sensitive to treatment (Kendall et 
al., 1997). Additionally, the CQ-C has demonstrated internal reliability (α = .69), strong 
parent-youth agreement (r = .46), and concurrent validity with other measures of 
childhood anxiety (Crane & Kendall, 2018).  
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Negative Affective Self-Statement Questionnaire (NASSQ; Ronan et al., 1994). 
 The NASSQ is a self-report measure that asks children to rate the frequency of 57 
anxious or depressive self-statements (e.g., “I thought I was going to do something 
wrong,” “I feel like everybody was looking at me and laughing”) and 13 positive self-
statements (e.g., “I feel good about myself,” “Nothing bothers me,” “I feel like jumping 
for joy”) within the past week. Ratings are made on a scale from 1 (not at all) to 5 (all the 
time). This measure has been shown to demonstrate acceptable internal reliability (α = 
.89-96) and 2-week test-retest reliability (α = .73 - .96). Additionally, the NASSQ has 
been shown to respond to cognitive behavioral treatments (Kendall et al., 1997; Ronan et 
al., 1994; Treadwell & Kendall, 1996). The NASSQ has also shown sufficient 
discriminant validity between individuals who are nonanxious and individuals who are 
clinically anxious. For the purpose of this study, the NASSQ was used to determine the 
frequency of negative self-talk.  
Physical Symptoms Checklist (PSC; Emslie et al., 2006) 
 The PSC is a 46-item self-report measure that reports the number of physical 
symptoms experienced by children within the past week (Emslie et al., 2006). Each item 
is rated on a 4-point Likert scale from 0 (not at all) to 3 (very much). A factor analysis 
demonstrated eight separate components: sleep, pain, panic, cardiac, upper respiratory, 
elimination, nausea, and skin (Emslie et al., 2006).  The PSC was used to determine 
frequency of physical symptoms.  
State-Trait Anxiety Inventory (STAI; Spielgberger, Gorsuch, Lushene, Vagg, & 
Jacobs, 1983) 
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 The STAI is a 20-item self-report measure that measures adult state and trait 
anxiety. State anxiety is the level of anxiety felt in response to anxiety-provoking 
situations (e.g., public speaking), while trait anxiety is a more chronic level of stress 
experienced by an individual (Spielberger et al., 1983). Each item is rated on a 4-point 
Likert scale from 1 (almost never) to 4 (almost always). The questionnaire asks adults 
about their general level of anxiety (e.g.,” I am tense,” “I am a steady person”) and 
anxiety in response to situations (e.g., “I worry too much over something that doesn’t 
really matter”). This measure has been shown to demonstrate acceptable test-retest 
reliability (α = .65 - .75) and acceptable internal consistency (α = .86 - .95; Spielberger et 
al., 1983). The STAI has also demonstrated sensitivity to predicting caregiver distress, 
changing with variations in support system and health (Elliot, Shewchuk, & Richards, 
2001; Shewchuk, Richards, & Elliot, 1998).  
Medical Questionnaire 
 Parents were asked to answer yes or no as to whether their children had asthma or 
another respiratory condition. This question was included in a larger demographic and 
medical history questionnaire completed by the parents.  
Responder vs. Non Responder: The Clinical Global Impressions-Investigator (CGI-
I) 
 The CGI-I (Guy, 1976) is a 7-point, one-item rating scale used by the investigator 
to assess for improvement in anxiety symptoms. In the original study, children were 
determined to be a responder to the treatment condition if their CGI-I score was either 1 
or 2 (Walkup et al., 2008). If their CGI-I was greater than 2, the child was not considered 
a responder.  
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Procedure 
Original Study Procedure 
 Participants were initially recruited through telephone-screening procedures to 
determine eligibility (Compton et al., 2010). The data from the SCARED, PARS, STAI, 
CQ-C, NASSQ, and PSC were collected during the pretreatment assessment at a variety 
of metropolitan sites throughout the United States. Specifically, participants were treated 
in the following cities: Philadelphia, PA; Los Angeles, CA; New York City, NY; 
Durham, NC; Baltimore, MD; and Pittsburgh, PA. During pretreatment assessment, 
researchers obtained informed consent and assent. Along with questionnaires, researchers 
provided a structured diagnostic interview to determine whether the child met criteria for 
one or more anxiety disorders. After pretreatment assessment, participants were then 
randomized into one of four treatment groups: CBT; sertraline; a combination of CBT 
and sertraline; and a pill placebo. Participants then completed 12 weeks of 
psychopharmacology treatment or 14 weeks of CBT or combined treatment (Compton et 
al., 2010). Following treatment, participants again completed a posttreatment assessment.  
Current Study Procedures 
 Data were obtained from the original CAMS database file after obtaining 
approval from the institutional review board (IRB) and the primary researchers of the 
original study. Participants were divided into two groups based on their answers to the 
asthma question on the medical history questionnaire. Children who had experienced 
asthma at any point in their lives per parental report were placed in one group, whereas 
children whose parents did not report a history of asthma were the comparison group. 
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SPSS was used to combine data from the questionnaires mentioned in this section and to 
run analyses.  
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CHAPTER 4: RESULTS 
Preliminary Analyses 
 Descriptive statistics were used to calculate demographic information in the 
specific sample. The data were split to analyze specific demographics between the group 
with asthma and the group without asthma. Demographic data are presented in Tables 4 
and 5. Although a significant difference was found in number of children with asthma 
compared to children without asthma, no significant group differences occurred in their 
gender, ethnicity (see Table 6), or age, t(484) = -.906, p = .365.  
Table 4 
Demographic Statistics for Asthma vs. Nonasthma Sample  
Factor Children with 
asthma 
Children without asthma 
Gender   
      Male 33 (37.5%) 134 (33.7%) 
      Female 55 (62.5%)  264 (66.3%)  
Race    
      Black   6 (6.8%)   38 (9.5%) 
      Asian   6 (6.8%)      6 (1/5%) 
      White 67 (76.1%) 317 (79.6%) 
      American Indian   2 (2.3%)     4 (1.0%) 
      Native Hawaiian/Pacific 
Islander 
  0 (0%)     2 (0.5%) 
      Other   7 (8.0%)   31 (7.8%) 
 
Table 5 
Means and Standard Deviations (SD) for Children’s Age 
Factor Children with asthma Children without asthma 
Age 10.86 (SD = 2.87) 10.65 (SD = 2.79) 
 
Table 6 
Chi-Squared Analyses Comparing Demographics 
Factors X2 N df Significance 
Gender     .469 486 1 .469 
Race 10.320 486 5 .067 
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Means and standard deviations of dependent variables are presented in Table 7. 
Additionally, frequency data for the Coping Questionnaire – Child (CQ-C) are presented 
in Table 8. When comparing the groups in terms of treatment response, all children in the 
asthma group were determined to be responders to treatment.  
Table 7 
Means and Standard Deviations for Outcome Variables 
Measures Children with asthma Children without asthma 
NASSQ 35.97 (18.19) 31.38 (17.21) 
PSC     .35 (.29)     .30 (.24) 
SCARED– Panic   4.23 (4.27)   4.38 (4.86) 
SCARED – General   6.85 (4.75)   6.05 (4.85) 
SCARED -Separation    4.86 (3.99)   4.24 (3.84) 
PARS (Pre) 19.14 (4.57)* 19.19 (4.11)* 
PARS (Post) 12.07 (5.53) 10.44 (5.27) 
STAI 37.28 (7.43) 39.06 (8.56)* 
*Indicates score higher than clinical cutoff for this measure 
Note. Abbreviation definitions are available in the Measures section. 
 
Table 8 
Frequency Results for the Coping-Questionnaire Situations 
Situation Domains Children with asthma Children without asthma 
Academic/Performance 
Concerns 
  43 (16.3%) 173 (14.8%) 
Social/Evaluation    Concerns 113 (48.2%) 452 (38.8%) 
Physical/Natural     Concerns   29 (11%) 195 (16.7%) 
School phobia/Refusal     1 (0.4%)     6 (0.5%) 
Specific Fear   17 (6.4%)   73 (6.3%) 
Separation Concerns   61 (23.1%) 266 (22.8%) 
 
An independent samples t test was conducted to determine whether youth with 
asthma and youth without asthma differed on pretreatment Pediatric Anxiety Rating 
Scale (PARS) scores. The independent samples t test was found not to be significant, 
t(483) = .101, p = .919 (M = 19.14, SD = 4.57).  
Inferential Statistics 
Hypothesis 1: Children with comorbid asthma and anxiety would exhibit 
higher levels of physical symptoms (PSC), panic symptoms (SCARED-Panic), 
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generalized anxiety symptoms (SCARED-GAD), separation anxiety symptoms 
(SCARED-Separation), and parental anxiety (STAI), when compared to children 
without comorbid asthma. A multivariate analysis of variance (MANOVA) was used to 
determine whether children with asthma would demonstrate higher rates of physical 
symptoms, parental anxiety, panic symptoms, generalized anxiety symptoms, and 
separation anxiety symptoms than children without asthma. The Levene’s test was found 
to be significant for physical symptoms; therefore homogeneity of variance was not met 
for this variable. However, despite adjusting significance for the Physical Symptoms 
Checklist (PSC; p < 0.05), the MANOVA did not demonstrate a statistically significant 
difference between children with asthma and children without asthma on any of the 
measures. MANOVA data are presented in Table 9.   
Table 9 
Multivariate Analyses for Hypothesis 1 
Measures df F Significance 
PSC 1 3.314 .069 
STAIT-S 1 3.232 .073 
SCARED-Panic 1   .009 .926 
SCARED-GAD 1 2.008 .157 
SCARED-
Separation 
1 1.879 .171 
Note. Abbreviation definitions are available in the Measures section. 
 
 
Hypothesis 2: Children with comorbid asthma and anxiety would 
demonstrate less general negative self-talk (NASSQ) than anxious children with 
anxiety but without asthma. A one-way analysis of variance (ANOVA) was conducted 
to determine if children with asthma demonstrated lower rates of negative self-talk on the 
Negative Affectivity Self-Statement Questionnaire (NASSQ) than children without 
asthma. The Levene’s test was not found to be significant (p = .553); therefore, 
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homogeneity of variance could be assumed. The analysis demonstrated a statistically 
significant difference between groups, F(1, 484) = 5.019, p = .026; the asthma group 
demonstrated higher scores on the NASSQ.  
 Hypothesis 3: Youth with comorbid asthma and anxiety would demonstrate 
higher occurrences of physical/natural worries (CQ-C) than children with anxiety 
but  without asthma. Three Pearson’s chi-squared analyses were performed to examine 
the relationship between asthma and worry themes. The relationships between these 
variables were not significant. Chi-squared analyses are presented in Table 10.  
Table 10 
Chi-Squared Analyses for Worry Content 
Factors X2 N df  Significance 
Situation 1 2.404 476 5 .791 
Situation 2 3.486 478 5 .626 
Situation 3 4.122 476 5 .532 
  
 Hypothesis 4: Children with comorbid asthma and anxiety would be less 
likely to be treatment responders than children with anxiety but without asthma. 
Alternatively, children  with comorbid asthma and anxiety would demonstrate 
higher levels of anxiety (PARS) in response to the treatment conditions (CBT, 
Sertraline, Combined CBT and Sertraline, and Placebo) when compared to children 
with anxiety but without asthma. Initially, a logistical regression was planned to 
determine whether children with asthma were less likely to respond to CBT treatment 
than children without asthma. However, descriptive statistics demonstrated that all 
children in the asthma group were treatment responders. Therefore, a 2 x 4 ANOVA was 
conducted to examine the effect of asthma on posttreatment anxiety scores (PARS) 
within the four treatment conditions (i.e., CBT, Sertraline, Combined CBT and Sertraline, 
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and Placebo). For the pre- and posttreatment PARS scores per group, refer to Table 7. 
The Levene’s test was found to be significant; therefore, homogeneity of variances could 
not be assumed (p < .01). As a result, the p value was increased to .05 to decrease the risk 
of making a Type I error. The analyses demonstrated a statistically significant main effect 
for treatment condition, F(3, 478) = 5.236, p = .001, ηp2 = .032, on anxiety scores, but the 
asthma main effect, F(1, 478) = 5.733, p = .017, ηp2 = .012, and the interaction of asthma 
and treatment condition were not significant, F(3,  478) = .997, p = .341. The distribution 
of each treatment group is presented in Table 11. 
 
Table 11 
Distribution of Participants in Treatment Groups 
Treatment 
Groups 
Youth with 
asthma 
Youth without 
asthma 
Combined 23 (26.1%) 124 (31.2%) 
Sertraline 18 (20.5%)   82 (20.6%) 
CBT only 27 (30.6%) 112 (28.1%) 
Placebo 20 (22.7%)   80 (20.1%) 
Note. CBT stands for Cognitive Behavioral Therapy. The combined group combined 
CBT treatment with sertraline.  
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CHAPTER 5: DISCUSSION 
 This study aimed to determine whether significant differences would be found in 
the characteristics and presentation of children with comorbid mild-moderate asthma and 
anxiety disorders when compared to children with anxiety but without asthma. 
Furthermore, this study investigated whether children with comorbid asthma and anxiety 
were less likely to respond to traditional cognitive-behavioral therapy (CBT) treatment 
than children with anxiety but without asthma. While none of the hypotheses in this study 
were supported, the findings provide important information about the relationship 
between asthma and anxiety diagnoses in children. Most significantly, findings suggest 
that traditional CBT protocols designed to treat anxiety may be an effective treatment for 
youth with asthma and anxiety comorbidity. This population may respond to treatment 
with some accommodations made for their specific concerns. A large limitation of this 
study must be addressed before interpreting results. While the overall sample obtained 
was 486, the number of children with asthma was only 88. This large discrepancy 
between groups makes determining statistical significance difficult despite the relatively 
large sample size.  
Parental Psychopathology, Anxiety, and Physical Symptoms 
 Children with comorbid asthma and anxiety did not show significant differences 
in regard to panic, generalized anxiety, or separation anxiety scores; parental 
psychopathology; and physical symptoms when compared to children with anxiety but 
without asthma. These findings suggest that children with asthma and anxiety 
comorbidity may not have a different profile or presentation of anxiety symptoms and 
etiological factors from those of children without asthma. In many cases, asthma may not 
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be as large of a precipitating factor in the development of anxiety disorders than initially 
hypothesized, at least in the case of mild to moderate levels of asthma.  
 First, in regard to the presentation of physical symptoms, the finding of no 
significant difference between children with asthma and anxiety and children with only 
anxiety may be explained in numerous ways. Children with asthma and anxiety 
comorbidity may not differ from children with anxiety but without asthma because of the 
high presentation of somatic complaints in anxiety disorders (Ginsberg, Riddle, & 
Davies, 2006). Younger children, especially, may be more likely to describe their anxiety 
symptoms in physical terms, as they may not yet have the vocabulary or cognitive skills 
to discuss anxious thoughts or cognitions. Children younger than age 9 years are less 
reliable in verbalizing their psychiatric symptoms than older youth (Edelbrock, Costello, 
Dulcan, Kalas, & Conover, 1985). Furthermore, not all symptoms on the Physical 
Symptoms Checklist (PSC) may overlap with asthma symptoms; symptoms associated 
with gastrointestinal issues (e.g., stomachaches, nausea, butterflies) may not be as 
prevalent in children with comorbid asthma and anxiety, but are often a common 
symptom in anxiety disorders.  
 Second, panic, generalized anxiety, and separation anxiety symptoms may not 
differ between the two groups because of many different factors. Most children with 
anxiety do not present with panic symptoms initially; panic disorder is often diagnosed in 
adolescence (Kessler et al., 2007). This presentation may hold true for children with 
asthma as well.  While children with asthma and anxiety may also feel separation 
concerns at times as a result of their asthma, these concerns may not significantly 
interfere with their functioning and may be more adaptive given their medical diagnosis. 
 69 
The separation anxiety scores for youth with asthma and anxiety were not clinically 
significant, indicating that their separation concerns were only mild. Mild concerns could 
also explain the nonsignificant findings with generalized anxiety symptoms. Instead, 
children with asthma and anxiety may present with a fear of negative evaluation resulting 
from their medical conditions. Despite their legitimate concerns regarding safety, 
symptom severity, and separation from parents, social anxiety may be more prevalent in 
youth with asthma and anxiety comorbidity (Bruzzese, Fisher, Lemp, & Warner, 2009) 
than youth without asthma. This prevalence has been previously demonstrated in children 
with other chronic medical conditions (i.e., Type 1 diabetes; Williams, Sharpe, & Mullan, 
2012), though more research is needed to understand the relationship between fear of 
negative evaluation and youth with asthma.  
 Finally, parental psychopathology may play an equal or similar role in the 
development of anxiety in children with asthma. The findings of this study are consistent 
with research that demonstrates parental influence can increase threat interpretation in 
children with asthma and anxiety (Sicouri et al., 2016; Sicouri et al., 2017b). Specifically, 
Sicouri et al. (2016) found that children with anxiety showed an interpretation bias 
toward general threatening situations, while children with asthma exhibited interpretation 
bias toward- asthma-threatening situations. Similarly, children with comorbid asthma and 
anxiety did not differ on their threat interpretation in comparison to the asthma alone and 
anxiety alone groups. Furthermore, parents of children with asthma were more likely to 
predict that their children would interpret asthma-related situations as threatening when 
compared to parents of children without asthma.. These results demonstrated that while 
parents may influence their children’s thought patterns regarding different threatening 
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situations, parents of children with asthma may provide a more adaptive approach for 
real-life threatening situations. Parents in the current study demonstrated anxiety that was 
considered clinical in nature; however, the heightened parental anxiety in this case may 
not be problematic. Instead, it may act as a helpful tool for increasing asthma control. 
Negative Self-Talk 
 Contrary to the initial hypothesis, youth with comorbid asthma and anxiety had 
significantly higher negative self-talk than youth with anxiety but without asthma. After 
taking a closer look at the questions in the Negative Affectivity Self-Statement 
Questionnaire (NASSQ), some may be conceived as fitting anxiety or asthma questions. 
For example, such items as “I feel like I am going to die” (Ronan et al., 1994) and other 
questions associated with dying and physical weakness may be positively endorsed by 
youth with comorbid asthma and anxiety as these items may be more related to realistic 
consequences of their medical condition. Also, items similar to “I get a nervous feeling 
like something is going to happen” (Ronan et al., 1994) can also be interpreted by youth 
with asthma as a medically related item. They may worry about the likelihood of an 
asthma exacerbation. Given the possible interpretations of NASSQ items, more research 
should investigate reliability, validity, and potential patterns in youth with comorbid 
asthma and anxiety. Thus far, scarce research has been conducted on the use of the 
NASSQ in youth with comorbid medical and psychological illnesses.  
 Research with adults has demonstrated that the NASSQ may be useful in medical 
populations. In a study involving adults with congenital heart disease, researchers 
demonstrated that the NASSQ may be helpful in predicting overall psychological 
adjustment to the medical diagnosis (Rietveld et al., 2002). Specifically, patients with 
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higher rates of negative self-talk reported higher rates of psychological distress. Again, 
research is limited regarding the use of the NASSQ and medical populations. Though the 
questionnaire was not initially developed with medical comorbidities in mind, further 
research may determine its usefulness in determining psychological functioning among 
youth with medical comorbidities.  
Given youth with asthma experience increased negative self-talk, this concept 
may guide treatment, especially in regard to cognitive restructuring. Clinicians should 
look closely at negative self-talk in youth with asthma and anxiety, understanding the real 
and potential threat their medical condition may have on their well-being; the negative 
self-talk may not be negative self-talk at all. Instead, it may act as an adaptive mechanism 
for controlling their asthma. This negative self-talk may also help guide safe, yet 
effective exposures for children and adolescents with asthma and anxiety comorbidity 
(e.g., using an inhaler in front of a peer). Informed of negative self-talk, the clinician may 
also help the youth problem solve certain anxiety-provoking asthma triggers in an 
adaptive way for their medical illness (e.g., take their cellphone and inhaler with them 
where they had previously experienced an asthma exacerbation).  
Worry Themes in Youth with Asthma and Anxiety 
 The current results of this study did not determine a significant relationship 
between asthma and anxiety comorbidity and specific themes of participants’ worries. 
The profiles of youth with comorbid asthma and anxiety and youth with anxiety only 
were similar in regard to the themes of their worries. These similarities may demonstrate 
again that children and adolescents with mild to moderate asthma may have concerns 
similar to those of their counterparts without asthma. Further, youth with comorbid 
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asthma and anxiety endorsed social and separation worries most often. While these 
frequencies were not significant, this data furthers the concept that children and 
adolescents with medical comorbidities may have increased fears of negative evaluation 
(Williams et al., 2014).  
 While panic disorder PD is one of the more common anxiety disorders comorbid 
with asthma (Dudeney et al., 2016), the prevalence of social-anxiety disorder should not 
be discredited. The increased social concerns in youth with asthma may be related to the 
social implications of their illness (Bruzzesse et al., 2009). Youth with asthma are 
required to take medications regularly, sometimes in public locations. These youth may 
feel embarrassed about taking this medication because of concerns regarding negative 
evaluation from their peers. Youth with asthma may also develop anxiety about 
participating in social activities, especially activities that may increase the likelihood of 
asthma attacks (e.g., recreational sports, physical exercise). These fears may cause 
adolescents to avoid social situations.  
 The increased rate of separation concerns in youth with asthma is consistent with 
current literature on the comorbidity of anxiety and asthma in youth. Separation anxiety 
disorder (SAD) is twice as common in children with asthma than in controls without 
asthma (Dudeney et al., 2016). This concept is in line with Rachman’s theory of anxiety 
acquisition (Rachman, 1977). In addition to classically conditioning to asthma stimuli 
and the development of an anxiety response to asthma triggers, children may also imitate 
their parent’s anxiety and develop vicarious fears from their parent’s anxiety. As a result, 
these children may learn to associate their parents with safety from asthma-related 
symptoms. Separation from parents can cue fears of uncertainty in regard to safety in the 
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event of an asthma exacerbation. Though this worry may be common and important to 
youth with asthma and anxiety, separation concerns may still be adaptive for their health.  
Response to Treatment 
 Youth with asthma and anxiety did not demonstrate significant differences in 
regard to treatment response when compared to youth without asthma. In fact, all the 
youth with asthma and anxiety comorbidity in this sample were treatment responders. 
These results demonstrate that youth with comorbid asthma and anxiety may benefit from 
traditional cognitive-behavioral therapy (CBT) and medication treatment for childhood 
anxiety.  These findings have many explanations. Few studies have examined tailored 
treatment of youth with asthma and anxiety; most of these studies have been pilot trials 
with small sample sizes and have yet to be replicated (Papneja & Manassis, 2006). 
Findings from the current study may demonstrate that children and adolescents with 
asthma and anxiety respond better to all treatment conditions (CBT, sertraline, and 
combined) than initially hypothesized. The tools introduced through the Coping Cat 
treatment may generalize to asthma-related anxiety stimuli.  Traditional CBT may also 
address all the concerns present in youth with comorbid asthma and anxiety, including 
family functioning (Keeton et al., 2013).  
Research on treatment for adults has demonstrated limited findings when 
integrating traditional CBT protocol with asthma interventions (Ross et al., 2005). While 
CBT treatment with asthma education (CBT-AE) demonstrated reductions in panic, 
generalized anxiety, and other anxiety characteristics, only reduced panic symptoms were 
maintained 6 months after follow-up. Furthermore, research with adults has been 
conducted using only waitlist comparison groups (Lehrer et al., 2008; Ross et al., 2005). 
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More information is needed in comparing the CBT-AT and CBT without asthma focus to 
determine if asthma-focused CBT treatment is more effective than traditional CBT.  
Flexibility within Fidelity  
Within CBT treatment is the concept of flexibility within fidelity (Kendall, 
Gosch, Furr, & Sood, 2008). This concept emphasizes the importance of adhering to 
evidence-based practice while also allowing flexibility and individualization of the 
protocol to meet the needs of the specific patient. Within traditional CBT treatment, 
flexibility within fidelity allows the clinician to adapt session protocol to the specific 
needs of the patient (Kendall et al., 2008). Patient interests, specific thoughts (e.g., I’m 
going to embarrass myself if I have an asthma attack in front of my friends), and specific 
fears are noted and integrated into the treatment protocol.  
Flexibility within fidelity may explain why youth with asthma and anxiety 
comorbidity were still responsive to traditional CBT treatments. During the treatment 
protocol, therapists were able to work with the youth to determine most appropriate 
coping thoughts, exposures, and rewards. This flexibility allowed the therapists the ability 
to integrate asthma-related fears into the treatment protocol when necessary. For 
example, if a child’s fear was using an inhaler in a public setting, the therapist was able to 
integrate this exposure into practice.  
Medication  
These results also demonstrate that youth with asthma and anxiety also responded 
to medication treatment (sertraline) and combined CBT with medication. Sparse research 
has been conducted on the use of psychotropic medications in youth with asthma. 
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Therefore, the current study is one of the first to determine that psychotropic medications 
may be beneficial in reducing overall anxiety for youth with asthma-related conditions.  
Generalizability  
These results are not generalizable to all youth with comorbid asthma and anxiety, 
however. Much is unknown regarding the presentation of asthma in the sample used for 
this study. Youth were excluded from the original study if they were suffering from a 
severe medical illness. Therefore, the youth involved in this study likely presented with 
mild to moderate asthma concerns. In that case, the asthma may not have played as large 
a role in the development of anxiety as previously thought. Research has demonstrated 
that children diagnosed with asthma, but who do not currently present with active 
symptoms, endorsed a positive quality of life (QOL; Annett, Bender, Lapidus, DuHamel, 
& Lincoln, 2001). Therefore, in the current sample, presenting anxiety may be less 
related to their medical illness and better treated by traditional cognitive and behavioral 
methods for childhood anxiety. The initial study was also conducted in outpatient mental-
health clinic settings. Participants were recruited from the public, rather than from 
medical or primary-care settings, and asthma was not a part of recruitment criteria. This 
sample selection potentially limited the number of children with asthma, especially those 
with active asthma symptoms, recruited in the initial study.  
Limitations 
Several limitations are associated with this study. As previously mentioned, the 
method of measuring asthma diagnosis was limited in providing detail of asthma 
symptoms. More information, such as severity, length of diagnosis, and asthma 
adherence, would be beneficial for understanding the sample. Furthermore, as the study 
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recruits were not drawn from a medical setting, active asthma symptoms could not be 
assumed. Recruiting the sample from an asthma clinic would provide more information 
regarding current active symptoms, asthma severity, and treatment protocol for these 
participants. With a medical sample, future researchers can facilitate collaboration 
between clinicians and medical professionals to incorporate asthma psychoeducation into 
treatment and push the boundaries of asthma-related exposures, with the guidance of a 
medical professional.  
Additionally, the content of the specific therapeutic sessions for these children is 
unknown. Having more information regarding the specific session content could help 
researchers determine whether asthma was addressed, and to what extent. Asthma might 
have been considered in treatment and incorporated into key therapeutic components, 
such as cognitive restructuring, problem solving, and exposures This information could 
help determine whether addressing asthma in the context of CBT treatment is beneficial 
to the participant’s progress.  
Future Directions 
Despite the limitations, this study demonstrated that CBT and 
phytopharmaceuticals may be an effective treatment for comorbid asthma and anxiety 
disorders. While clinicians should be aware of how asthma may affect anxiety 
presentation, they should not discount traditional CBT for treatment. Yet, clinicians 
should also be aware that some techniques may need to be adapted specifically to the 
reality of asthma. Additionally, previous research has demonstrated that asthma 
adherence psychoeducation can be an effective complementary treatment to standard 
CBT for anxiety and asthma; however, more research is needed to demonstrate the 
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effectiveness of these treatments. Further research should compare traditional CBT to 
specific asthma-related protocols mentioned previously to determine if these treatments 
are equally effective or if one may be more beneficial for youth with asthma and anxiety 
comorbidity. Additionally, researchers should also recruit from medical facilities, 
including asthma clinics, to determine the severity of asthma, frequency of attacks, and 
other important diagnostic information that may be relevant to anxiety presentation and 
treatment.  
Further research is also needed to understand asthma as a potential risk factor for 
developing anxiety disorders. While researchers know what makes children generally 
more susceptible to anxiety, more information is needed about children specifically with 
asthma. Does the mortality of their medical condition predispose them to develop 
anxiety? Do other factors facilitate the development of anxiety disorders in youth with 
asthma? This information can contribute to the development of specific protocols or 
adaptation of traditional CBT for treating children with comorbid asthma and anxiety. 
Differences in temperament and thinking styles may affect treatment responses. 
Therefore, focusing more treatment sessions on specific characteristics, such as an 
increase in realistic physical worries, rather than attempting to restructure negative 
cognitions may be necessary.  
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